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ABSTRACT

Examining Financial Stress and Coping among U.S. Cancer Patients and Survivors: Quantitative
Analyses of Survey Data
by
Meredith Doherty

Advisor: Dr. Daniel Gardner

Financial hardship, a growing problem for cancer patients and survivors, is associated
with increased pain and symptom burden, reduced quality of life and psychological wellbeing,
poor treatment adherence, and early mortality. Nearly one in three cancer patients reports that
cancer caused some financial stress or strain. Emerging research has begun to explore the coping
strategies used by cancer-affected individuals to manage the direct and indirect costs associated
with cancer and its treatment. This dissertation seeks to answer three research questions: (1) what
are the measurable characteristics of different cost-coping strategies? (2) what behavioral,
institutional, and social factors are associated with variations in coping? and (3) to what extent
do these distinct coping strategies mediate and/or moderate the relationship between material
financial stress and perceived financial strain?
To address these research questions, multivariate statistical methods were used to analyze
existing survey data on the financial concerns from a stratified, random, national sample of
insured cancer patients and survivors (N = 511). Exploratory factor analysis was used to identify
the four underlying dimensions of problem-focused cost-coping and delineate working scales for
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each hypothesized coping strategy: care-altering, lifestyle-altering, self-advocacy and financial
help-seeking. Stepwise logistic regression was used to model significant predictors of each costcoping strategy. Lastly, to explore the possible effectiveness of each cost-coping strategy, linear
regression-based mediation and moderation modeling using Hayes’ PROCESS analysis was used
to measure the extent to which each strategy intervened in the relationship between material
financial stress and the perceived financial strain.
Two strategies played meaningful intermediary roles: lifestyle-altering and selfadvocacy. Lifestyle-altering, used more often by women and people of color, partially mediated
the positive, linear relationship between stress and strain (B = 0.08, p<.05). Self-advocacy
interacted with stress to buffer its impact on perceived financial strain (B=-0.01, p<.01).
Findings from this study contribute to the literature on financial stress and strain as social
determinants of health by proposing a model of financial coping in cancer that may facilitate the
development of interventions, programs and policies that improve financial wellbeing in people
affected by cancer by supporting successful coping and targeting the delivery of material and
psychosocial resources where they are needed most.
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CHAPTER I. STATEMENT OF THE STUDY ISSUE
Rationale and Significance
People diagnosed with cancer are materially and psychologically unprepared to deal with
the costs of care. They typically encounter unexpected out-of-pocket medical expenses and may
be limited in their ability to work for periods of time (CancerCare, 2016; Yabroff et al., 2015).
The combined financial burden of treatment and potential for lost income is a major source of
stress for people affected by cancer (Altice, Banegas, Tucker-Seeley, & Yabroff, 2017; Azzani,
Roslani, & Su, 2015). Moreover, a growing number of studies have linked this experience of
financial hardship to poor health outcomes and early mortality (Ramsey et al., 2016; Zafar &
Abernethy, 2013).
Financial hardship in cancer is widespread and growing. Each year almost two million
American men and women receive a diagnosis of cancer, and there are currently over 15.5
million cancer survivors in the United States (American Cancer Society, 2016; Siegel, Miller, &
Ahmedin, 2016). At least one third will experience a degree of financial hardship due to out-ofpocket medical expenses and wages lost due to disability (Yabroff et al., 2015). For many,
cancer-related financial hardship persists beyond the acute phase of their illness and throughout
survivorship (Jagsi et al., 2014). Coping with these expenses affects not only the person with
cancer, but their family, and the wider community as well.
The treatment advances of recent decades have improved survival and decreased overall
mortality from cancer, but have also added significant cost to standard treatment protocols.
Cancer patients have substantially greater out-of-pocket treatment costs and 2.5 times the risk of
personal bankruptcy of people with other health conditions (Cohen, Gindi, & Kirzinger, 2012;
Claxton, Panchal, Whitmore, Damico, Kenward, & Long, 2015; Ramsey et al., 2013). Even after
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active treatment cancer survivors are more likely to have high personal debt and negative net
worth, and are less likely to own homes than people without a cancer history (Doroudi,
Coughlan, Banegas, Han, & Yabroff, 2018).
In response to rising healthcare costs, many insurance plans have employed cost-sharing
mechanisms that increasingly shift the burden to patients in the form of co-insurance, co-pays,
deductibles and monthly premiums (Collins, Rasmussen, Beutel, & Doty, 2015). Cost sharing
related to prescription medication, outpatient care and hospital stays constitute the greatest
portion of these expenses, respectively (Zafar & Abernethy, 2013). In a 2016 survey conducted
by the national organization CancerCare, respondents between the ages of 25-64 reported
average monthly out-of-pocket expenses of $1,112 for their cancer treatment (CancerCare,
2016). Similarly, a recent analysis of 2002-2012 Health and Retirement Study data indicated that
the average annual out-of-pocket cancer treatment costs in a nationally representative sample of
1,409 traditional Medicare beneficiaries was $8,115 (Narang & Nicholas, 2016). For context, the
median household income in 2015 was $38,515 for individuals 65 and older (U.S. Census
Bureau, 2017), suggesting that many individuals may spend over 20% of their household income
on out-of-pocket cancer costs.
Individuals and families who spend 10-20% or more of their household income on outof-pocket medical expenses are considered underinsured (Collins et al., 2015) . The number of
underinsured Americans is climbing. According to the 2014 Commonwealth Fund Biennial
Health Insurance Survey, the number of underinsured Americans nearly doubled from 16 million
in 2004 to 31 million in 2014. For the underinsured, high out-of-pocket costs can lead to large
amounts of debt, personal bankruptcy and difficulty adhering to treatment (Collins et al., 2015;
Dusetzina, Winn, Abel, Huskamp, & Keating, 2014; Kaisaeng, Harpe, & Carroll, 2014). A recent
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study found that the gains in coverage rates secured by the Patient Protection and Affordable
Care Act of 2010 did not reduce the number of bankruptcies caused by serious illness and its
treatment (Himmelstein, Lawless, Thorne, Foohey, & Woolhandler, 2019).
The excessive cost of care has well-documented health consequences. A growing body of
evidence has linked cancer-related financial hardship to adverse health and treatment outcomes.
Strong associations have been documented between cancer patients’ experience of financial
hardship and reduced quality of life (Arastu et al., 2018; Fenn, 2014; Kale & Carroll, 2016;
Lathan et al., 2016, 2016; Zafar et al., 2015), increased pain and symptom burden (Chan et al.,
2018; Delgado-Guay et al., 2015; Lathan et al., 2016; Rios & Zautra, 2011), and early mortality
(Ramsey et al., 2016). Furthermore, patients who experience financial hardship are more likely
to report treatment delays (Casilla-Lennon et al., 2018; Wharam et al., 2019) and difficulty
adhering to treatment. Many report delaying or forgoing recommended treatments and cutting
back on prescribed medications to reduce their out-of-pocket costs (Bestvina et al., 2014). The
term financial toxicity is now used to refer to the demonstrated impact of financial hardship on
these health and treatment-related outcomes (Zafar & Abernethy, 2013). Such outcomes are
distinct from health outcomes associated with low socioeconomic status alone, and have been
identified across the spectrum of income and insurance status. As such, financial toxicity is
increasingly cited as a common side effect cancer care, as well as a social determinant of health
(Tucker-Seeley & Yabroff, 2016).
Although financial toxicity has been reported by individuals across the socioeconomic
continuum (Tucker-Seeley & Yabroff, 2016) studies have shown that women, individuals
identifying as racially/ethnically nonwhite, non-English speakers and those with lower
educational attainment are more likely to experience cancer-related financial hardship and its
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attendant health consequences (Knight et al., 2018; Ramsey et at., 2016; Shankaran, Jolly,
Blough, & Ramsey, 2012). These studies build upon well-documented racial/ethnic and
socioeconomic disparities in cancer incidence and mortality (Ward et al., 2004). Financial
toxicity may represent a downstream social determinant of health and a potential driver of cancer
health disparities for socially disadvantaged communities.
The construct of cost-coping describes the strategies used by cancer patients and
survivors to manage financial stress and balance their personal and household financial needs
with the costs of treatment (Zullig et al., 2013). Although the literature posits multiple costcoping strategies (Head, Harris, Kayser, Martin, & Smith, 2018; Nipp et al., 2016) and has
implicated cost-coping in the development of negative health effects (Carrera, Kantarjian, &
Blinder, 2018; Zafar, 2016), in-depth knowledge of the range of strategies used by financially
stressed households is sparse. There is reason to believe that cost-coping strategies can either
buffer or exacerbate the impact of financial stress on health and wellbeing. Citing threats to
public health, oncology providers and researchers have called for evidence-informed strategies to
prevent financial stress and coping from undermining patient care and outcomes (Tucker-Seeley
& Yabroff, 2016).
Social Work Role
Guided by the ethical principle of promoting social justice, the social work profession is
commited to eliminating race- and class-based health disparities and building the financial
capacity of underserved communities (National Association of Social Workers [NASW], 2017;
Uehara et al., 2013). In many health care settings social workers are responsible for identifying
and addressing patients’ financial needs and concerns. Oncology social workers have cited
financial and insurance difficulties as the foremost barrier to accessing high quality cancer care
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(Burg et al., 2010) and have called for improved screening and financial resource identification
tools (Smith, Nicolla, & Zafar, 2014).
A deeper, more contextual understanding of financial stress and coping can inform the
development of social work assessment and interventions that promote effective coping and
financial wellbeing in cancer patients and survivors. A working measure of cost-coping can be
useful in development of clinical tools that can be used to identify individuals at risk of financial
stress, strain, and maladaptive coping strategies. Understanding the risk factors associated with
different coping strategies may aid in the development of targeted community and population
level interventions that direct material and psychosocial resources where they are needed. This
study contributes to an emerging literature that posits cancer-related financial hardship as a
health equity issue which disproportionately impacts women, the poor, and people of color.
Specific Study Aims
This exploratory study seeks to improve our understanding of the problem-focused costcoping strategies used by cancer patients and survivors by (1) identifying the measurable
characteristics of cost-coping and its subdimensions; (2) identifying the behavioral, social and
health system factors that predict variations in coping; and (3) measuring the extent to which
different coping strategies mediate or moderate the relationship between material financial stress
and the subjective experience of financial strain. In order to address these aims, I conducted an
analysis of secondary, cross-sectional data from an online survey of cancer patients and survivors
(n=511) regarding their concerns about finances and health insurance. The overarching goals of
the study are to produce a formative, working measure of cost-coping, identify modifiable
factors associated with variations in coping, and measure the extent to which coping strategies
succeed in buffering the impact of financial stress on wellbeing to develop a preliminary model
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of financial hardship and cost-coping in cancer patients and survivors. Specifically, the study
seeks to test the following hypotheses and accomplish the following aims:
Aim 1
Identify, through exploratory factor analysis techniques, measurable characteristics of
cost-coping and its subdimensions in the survey data. H1: Cost-coping is a measurable latent
construct that can be measured across multiple subdimensions.
Aim 2
Identify behavioral, social, and health system factors that most strongly predict variations
in cost-coping. Specifically, stepwise logistic regression is employed to predict cost-coping
outcomes from behavioral (e.g. patient activation score), health system (e.g. health insurance
type and associated out-of-pocket medical costs), and social (e.g. gender, race/ethnicity, and
income). H2: Coping style will vary by behavioral, health system, and social factors such that,
upon examination of multiple indicators, distinct typologies and modifiable factors will emerge.
Aim 3
Measure, using Hayes’ PROCESS method of regression-based mediation and moderation
analysis, the extent to which different cost-coping strategies mediate or moderate the relationship
between material financial stress (i.e. difficulty paying bills due to cancer treatment) and
financial strain (i.e. psychological distress attributed to finances). H3: Each cost-coping strategy
will have a distinct and measurable impact on the relationship between financial stress and
financial strain.
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CHAPTER II. REVIEW OF THE LITERATURE
Financial Stress and Strain
One of the challenges of conducting research on financial hardship in cancer is the lack
of consistency in naming and defining the phenomenon. Financial hardship encompasses both
the subjective and objective experiences of cancer patients and survivors when they encounter
difficulties balancing their household financial responsibilities with the direct and indirect costs
associated with their cancer diagnosis. One way of understanding the construct divides it into
two dimensions: financial stress and financial strain. Financial stress represents objective,
measurable financial demands, and financial strain represents one’s subjective perception of
difficulty or distress related to managing those demands (Francoeur, 2005; Sharp, Carsin, &
Timmons, 2013). Both financial stress and strain have been associated with adverse
psychological outcomes including increased distress, depression, and anxiety in cancer patients
and survivors (Ell, et al., 2008; Sharp, et al., 2013). Individuals and groups vary in the degree to
which financial stress leads to subjective strain. Although financial stress and strain tend to be
significantly correlated on average, the pattern and strength of the relationship depends on
mediating and moderating factors, including a patient’s ability to rally personal and social
resources in order to cope with stress (Francoeur, 2005).
Cost-Coping Strategies
In their conceptual framework of financial hardship in cancer, Altice and colleagues
(2017) added a third feature to the stress and strain model: coping behaviors. Their model
proposed three distinct but overlapping dimensions: (1) material conditions, (2) psychological
responses, and (3) coping behaviors. Their review of the empirical literature identified patterns in
measuring these three dimensions. The material conditions typically measured in research on
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financial hardship include out-of-pocket expenses, missed work, lost income, medical debt and
bankruptcy. Psychological responses are often measured in terms of subjective distress about
managing household finances after or during cancer treatment. Coping behaviors they identified
in the literature related to care- and lifestyle-altering behaviors like delaying or forgoing medical
care, reducing medications to save money, and cutting back on essential and non-essential
household spending.
Despite the abundant and growing body of literature on financial hardship, coping
strategies have been relatively understudied (Carrera et al., 2018). Coping falls broadly into two
types: (1) person-oriented/emotion focused and (2) task/problem focused (Head, et al., 2018;
Lazarus & Folkman, 1984). In qualitative interviews with financially-burdened cancer patients,
Head and colleagues (2018) identified a number of emotion and problem focused coping
strategies. In their study they found people were engaged in emotion focused cost-coping
strategies like using personal strengths, accessing social support, expressing emotion and
engaging in self-care. They also described problem focused strategies like going into debt,
accessing financial assistance, making lifestyle changes, changing treatment protocol, being
proactive and negotiating with insurance.
Care-altering and lifestyle-altering are two cost-coping strategies that have received the
most scholarly attention to date (Bestvina et al., 2014; Huntington et al., 2015; Irwin et al., 2014;
Jagsi et al., 2014; Kent et al., 2013; Lee & Khan, 2016; Lee & Salloum, 2016; Nipp et al., 2016;
Zafar, Chino, Ubel, Rushing, & Samsa, 2015; Zullig et al., 2013). As stated previously, carealtering describes how some cancer patients and survivors cope with the cost of their care by
delaying or forgoing aspects of medical treatment. Lifestyle-altering refers to coping with the
costs of care by altering spending and borrowing habits (Nipp et al., 2016).
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Care-altering, also referred to as cost-related nonadherence (CRN), has been associated
with adverse health consequences in cancer and other illnesses (Hershman et al., 2011; Osterberg
& Blaschke, 2005). Although the exact estimates are unknown, two large population-based
studies using data from the National Health Interview Survey from 2003-2006 (Weaver,
Rowland, Bellizzi, & Aziz, 2010) and 2010 (Kent et al., 2013) concurred that 10-20 percent of
cancer patients and survivors had delayed or declined necessary medical care in the last 12
months due to cost.
The only reliability-tested measure of care-altering is a measure of cost-related
medication nonadherence. Respondents are asked if in the last six months they have ever skipped
a dose of medication, took a smaller dose, or delayed refilling, and how many times in the last 12
months they did not fill a prescription (Pierre-Jacques et al., 2008). Many care-altering and CRN
studies adapted this instrument to measure other kinds of treatment nonadherence, like delaying
or forgoing medical appointments and testing.
The two primary drivers of care-altering that have been identified in the empirical
literature are financial hardship and high out-of-pocket medical costs. The risk of engaging in
cost-related medication nonadherence has been positively correlated with rising prescription copayments (Dusetzina et al., 2014; Kaisaeng et al., 2014; Neugut et al., 2011; Streeter,
Schwartzberg, Husain, & Johnsrud, 2011) and self-reported financial stress and strain (Kent et
al., 2013; Markman & Luce, 2010; Zafar et al., 2013; Zullig et al., 2013). Other factors that have
been empirically linked to care-altering behavior in past studies are age, race/ethnicity and
gender. Analyzing a nationally representative sample of cancer patients and survivors, Lee and
colleagues found that younger patients, women, African American and Hispanic individuals
were more likely to cite treatment costs as a barrier to adherence (Lee & Khan, 2016; Lee &
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Salloum, 2016). These demographic disparities by age, gender and race are persistent and have
also been found in smaller, less heterogeneous study samples (de Souza, Kung, O’Connor, &
Yap, 2017; Martin, Shreffler, Schoster, & Callahan, 2012; Zafar et al., 2013).
People respond to financial hardship and out-of-pocket costs differently. Under the same
financial circumstances, only some patients respond by altering care and reducing adherence to
treatment and medication (Briesacher, Gurwitz, & Soumerai, 2007). Piette et al. (2006) proposed
a conceptual model of factors influencing care-altering behavior in people with chronic illness.
The model proposes that there are, in addition to primary financial pressures, interactional
factors related to clinician, patient, health system and medication characteristics that increase
one’s risk of care-altering (Piette, Heisler, Horne, & Alexander, 2006). Patient-physician trust
(Piette, Heisler, Krein, & Kerr, 2005) and patient health beliefs (Piette, Beard, Rosland, &
McHorney, 2011) have been identified as possible mediators of the relationship between
financial hardship and care-altering. Efforts to identify other modifiable factors associated with
care-altering behavior is ongoing.
Like care-altering behaviors, lifestyle-altering strategies range in severity. Some cope
proactively by simply cutting back on leisure spending, while other people are driven to cut back
on basics like food and clothing or to depleting assets, borrowing money and filing for
bankruptcy (Altice et al., 2017). As a singular concept, lifestyle-altering has been relatively
understudied and efforts to operationalize and measure it are incomplete. However, aspects of
lifestyle-altering such as changing spending habits, borrowing money, and filing for bankruptcy
have been well-documented (Altice et al., 2017; Head et al., 2018; Nipp et al., 2016). Nipp and
colleagues (2016) delineated lifestyle-altering cost-coping with the following survey items
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(adapted from Schrag et al., 2009): reduced spending on basics and on leisure activities,
borrowed money, used savings, family worked more, and/or sold possessions.
Many studies of lifestyle-altering have used small, convenience samples which make it
difficult to estimate its prevalence. However, the accumulated evidence suggests that many
cancer patients and survivors alter their lifestyle, spending and borrowing habits to accommodate
the costs of treatment (Jagsi et al., 2014; Markman & Luce, 2010; Meneses, Azuero, Hassey,
McNees, & Pisu, 2012; Shankaran et al., 2012; Zafar et al., 2013; Zafar et al., 2015). For
example, in studies of cancer patients who had contacted a financial assistance program, 68-78
percent cut back on leisure activities, 46-57 percent reduced spending on basics like food and
clothing, and 46 – 50 percent used savings to pay for treatment (Nipp et al., 2016; Zafar et al.,
2013). Patients commonly borrow from friends, family and banks to cover expenses, such that
nearly 3 percent of American cancer survivors file for bankruptcy within two years of diagnosis
(Meneses et al., 2012; Nipp et al., 2016; Zafar et al., 2013).
In addition to the potential for lifestyle-altering to affect quality of life (Meneses et al.,
2012), some of these coping strategies have been shown to impact physical health outcomes. A
2016 study conducted by Ramsey and colleagues (2016) revealed that cancer survivors who filed
for bankruptcy died earlier than propensity score matched counterparts who had not filed for
bankruptcy. These findings suggest that some forms of care- and lifestyle-altering coping are
potentially dangerous, and may carry higher risks for health and wellbeing than other cost-coping
strategies.
Predictors of Financial Stress and Variations in Coping
Financial hardship has been reported across demographic populations but is known to
disproportionately impact younger patients, women, and African American and Hispanic
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individuals (Ramsey et al., 2016; Shankaran et al., 2012). These associations persist across
studies despite some differences in the definition and measurement of financial hardship (Altice
et al., 2017).
Nipp and colleagues (2016) conducted a small study (n=174) using a cross-sectional
survey to disentangle care-altering and lifestyle-altering strategies and identify predictors of each
coping style among adult cancer patients receiving financial assistance program. To predict each
cost-coping outcome, they examined the following patient characteristics: age, marital status,
race, income, education, chemotherapy duration, cancer site, and presence of metastatic disease.
They found that both care- and lifestyle-altering were associated with younger age (< 65), lower
income, higher education, non-breast cancer diagnosis and non-metastatic disease. Among these
respondents, those at risk for care-altering, rather than lifestyle-altering, were more likely to be
younger (<65) and have lower incomes (< $20,000/year). Unlike other studies, race/ethnicity was
not significantly associated with financial hardship and cost-coping.
The study by Nipp et al. (2016) surveyed a small sample that overrepresented individuals
with breast cancer, and had a low response rate, so findings may not accurately reflect the
general population of cancer patients and survivors. When designing the measure and developing
statistical models, the researchers did not include behavioral factors that might have provided
psychological insight into what motivates people to cope with financial stress in different ways.
Similarly, positive coping like self-advocacy and help-seeking were not examined. Further
research is needed to develop distinct, comprehensive typologies of cost-coping which can be
used to identify patients who may be at risk of engaging in riskier coping strategies like carealtering.
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The extent to which past studies of financial hardship and cost-coping were explicitly
informed by social or behavioral theory is unknown. There is a clear conceptual connection to
the theories, models and frameworks that form the social determinants of health research
paradigm. For example Pearlin’s Stress Process Model (Pearlin, 1989; Pearlin, Menaghan,
Lieberman, & Mullan, 1981), described in the next section, provides a rationale and framework
for examining the mediating effects of coping on the relationship between financial stress and
strain. However, Pearlin’s model has not been applied to an empirical examination of costcoping in cancer patients and survivors. The following section presents how this theoretical
framework will guide each of the research aims.
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CHAPTER III. CONCEPTUAL FRAMEWORK
This study is conceptually organized by Pearlin’s Stress Process Model, a sociological
adaptation of stress and coping theory. The Stress Process Model invokes social structural
relationships to illustrate the processes of toxic stress development that are thought to underlie
the disparities in health attributed to differences in race, gender, and socioeconomic status.
Expanding upon Selye’s original conceptualization of stress (Selye, 1956), the Stress
Process has three elements: (1) stressors, (2) stress mediators, and (3) stress outcomes (Pearlin et
al., 1981). Stressors can be thought of as threatening or burdensome experiences that an
individual must respond to, stress mediators are internal and external resources that individuals
leverage to manage stressful experiences (e.g. coping). Stress outcomes are the effects of
stressful experiences, such as distress and other health effects (Pearlin, 1989). In this model, both
stressors and stress mediators are determined by psychosocial and environmental factors like
socioeconomic status and social role.
Early stress and coping theory emphasized internal, psychological processes (Lazarus,
1993). But has since grown to include social and relational factors. Link and Phelan (1995)
proposed a link between social stress and illness, proposing that socioeconomic status functions
as a fundamental cause of health disparities that cannot be fully accounted for by individual
behavior or lifestyle factors. Like earlier theories of stress, the sociological perspectives
acknowledge that stress has a direct impact on physical and mental health, but adds that social
roles and socioeconomic status determine the type and magnitude of stress that one is exposed to.
This differential exposure to stress is thought to be responsible for health outcomes that vary by
race, gender, marital status and income (Thoits, 2010). Stressors can be acute, life events or they
can be chronic conditions that allow stress to proliferate across the life course and across
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generations (Aneshensel, 1992; Thoits, 2010). In a persistently inequitable society, race, class
and gender can be considered primary sources of stress (Dohrenwend & Dohrenwend, 1970).
People vary in their vulnerability and response to stress. This may be attributed to their
ability to cope with stressful experiences, since coping has been shown to reduce the impact of
stressors (Thoits, 2010). Coping, when personal and social resources are rallied to manage a
stressful experience, is thought to mediate the impact of stress on physical and mental health
outcomes. Coping strategies are characterized as emotion- or problem-focused, and have
differing degrees of success in proactively managing stress (Lazarus, 1993). Emotion-focused
strategies focus on managing thoughts, perceptions and feelings to reduce stress, while problemfocused coping attempts to reduce stress by changing the external circumstances. Not all coping
strategies produce positive outcomes. Some strategies exacerbate primary stressors, causing
further problems and producing secondary and tertiary compounding stressors (Pearlin, 1989;
Pearlin & Bierman, 2013). Coping is, as well, a socially-situated phenomenon that varies by
one’s access to psychosocial and material resources (Thoits, 2006).
Conceptually and methodologically, coping can function as either a mediator or
moderator of the impact of stressors on stress outcomes (Frese, 1986). Coping acts as a mediator
when it links stressors to stress outcomes in a causal pathway. It should therefore be significantly
correlated with both the antecedent stressor and the stress outcome. When coping acts as a
moderator, it interacts with the antecedent stressor to either increase or decrease the stressor’s
effect on the outcome. This study applies the Stress Process Model to develop a model of
financial hardship and cost-coping in cancer patients and survivors (see Figure 1), and tests
coping as a mediator (see Figure 2) and moderator (see Figure 3) of the stress process. Financial
stress acts as the stressor and financial strain acts as the stress outcome.
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Figure 1. Stress process model adapted for financial stress and cost-coping. Adapted from
Understanding health disparities: The promise of the stress process model (p. 5), by R.J. Turner.
In W.R. Avison, C.S. Aneshensel, S. Schieman, & B. Wheaton (Eds.). Advances in the
conceptualization of the stress process: Essays in honor of Leonard I. Pearlin, 2009, New York,
NY, Springer Science and Business Media.

Figure 2. Cost-coping as a mediator in the stress process
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Figure 3. Cost-coping as a moderator in the stress process
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CHAPTER IV. METHODOLOGY
Overview
This exploratory study examined the cost-coping strategies of adults living with cancer by
conducting secondary analysis of cross-sectional survey data on the financial concerns of 511
cancer patients and survivors, described further below (CancerCare, 2016) . The study was
designed to achieve three specific aims:
Aim 1: Apply factor analysis techniques to survey data to develop a preliminary measure of costcoping and its subdimensions.
Aim 2: Use step-wise logistic regression to model the significant social, behavioral and health
system factors that most strongly predict variation in cost-coping.
Aim 3: Measure the extent to which each cost-coping strategy mediates and/or moderates the
relationship between financial stress and strain.
3a) Regression-based simple mediation model to measure extent to which each coping strategy
explains the impact of financial stress on the experience of financial strain.
3b) Regression-based moderation models to measure the extent to which each strategy either
buffers or amplifies the impact of financial stress on the experience of financial strain.
Design and Sample
Cross-sectional survey data for this dissertation have been provided by CancerCare, a
non-profit psychosocial support organization for people affected by cancer (see Appendix 2 for
data use agreement). Between July and December 2015 CancerCare conducted the “Cancer
Patient Access and Engagement Study”, a series of six online cross-sectional surveys on the
experiences of cancer patients and survivors across the continuum of care. The surveys were
developed by CancerCare staff in collaboration with leaders in oncology research to capture and
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describe the unmet needs of U.S. cancer patients and survivors across six areas of care: (1)
understanding the diagnosis of cancer; (2) treatment planning; (3) communication with the care
team; (4) financial and insurance issues; (5) symptoms, side effects and quality of life; (6)
survivorship. The surveys were pilot-tested with a sample of CancerCare participants for
feasibility and then administered online to a sample drawn from national market research panels.
To participate, respondents had to: (1) be 25 years of age or older, (2) have ever been
diagnosed with cancer by a medical professional, and (3) have health insurance. Respondents
were drawn from national consumer panels used in market research and contacted by email to
participate in an online survey about their experiences accessing and engaging in health care.
Approximately 3,000 email invitations were sent out per survey. Online filters were used to
select a purposive, stratified sample of cancer patients and survivors to represent population
distributions by U.S. geographic region and cancer type. To match U.S. national demographic
data, approximately 25% of respondents were selected to represent each geographic region
(Northeast, Southeast, Western US, and Midwest). Fifty percent of participants were drawn to
represent the major cancer-types (breast, colorectal, lung, and prostate cancer) and the remaining
half represented all other cancers excluding non-melanoma skin cancer (CancerCare, 2016).
This dissertation analyzed data from one of the six surveys from the original study, the
survey of patients’ financial and insurance concerns which was completed 511 cancer patients
and survivors. If 3,000 invitations were sent then 17% of those contacted were both eligible to
participate and completed the survey (see Table 2 for sample characteristics). As a secondary
data analysis, this dissertation posed unique research questions that were not asked in the original
descriptive study and tested hypotheses for financial hardship and coping that were not part of
the original study. Sample characteristics can be found in Table 2.
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Measures
The survey includes 51 items related to the financial impact of cancer and coping with
the cost of care. Some of the items are unique to this study and others were drawn from federal
health service research surveys like the National Health Interview Survey and the Medical
Expenditures Panel Survey (Yabroff et al., 2012). Only one measure in the survey has been
psychometrically evaluated in past studies, the patient activation measure (PAM-10), a validated
and reliable measure designed to assess individuals’ ‘self-concept as manager of their own health
needs’ where higher scores indicate higher activation (=0.82) (Hibbard & Gilburt, 2014, p. 8).
Cost-coping
To estimate cost-coping, 32 survey items were selected from the 51 items that constitute
the original survey. The principal investigator selected these items following a comprehensive
review of the scholarly literature on financial stress and coping in cancer. The items selected are
similar to the unvalidated measures used in past studies Jagsi et al., 2014; Nipp et al., 2016;
Zullig et al., 2013).
“How often (never, rarely, sometimes, often or always) did/do you do each of the following in
order to reduce your expenses related to your cancer treatment… (1) postpone or skip medical
appointments; (2) postpone or skip follow up testing; (3) postpone or skip bloodwork; (4) delay
or skip complementary treatment; (5) postpone or skip psychological support; (6) skip dosage of
prescribed drugs; (7) cut pills in half; (8) apply for copay assistance for medication; (9) discuss
changing treatments to one that costs less; (10) choose a lower cost medication than what the
doctor recommended; (11) apply for financial assistance for non-medical expenses; (12) order
medication from outside US online; (13) apply for financial assistance from my doctor; (14)
estimate cost before agreeing to treatment; (15) appeal a denial of benefit from you insurance
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company; (16) find out cost before filling a prescription for side effects/symptoms; (17) estimate
cost before going to emergency room; (18) review the explanation of benefits from insurance
company; (19) ask insurance company for help understanding coverage; (20) find out cost of lab
test or scans before agreeing to treatment; (21) considered changing to a different doctor because
of cost; (22) considered a non-traditional treatment that costs less.”
“Which of the following have you experienced as a result of bills related to your cancer
treatment (yes or no)…(23) I declared bankruptcy; (24) I borrowed money from a bank or credit
union; (25) I cut back on non-essential items; (26) I borrowed money from family/friends; (27) I
moved to a less expensive home; (28) I missed rent/mortgage payments; (29) I cut back on
groceries, transportation, clothing, tuition; (30) I missed paying bills like heat, electricity, phone;
(31) I asked for financial help from a church or community organization; (32) I applied for
financial assistance from a patient support organization.”
Domain 1: Demographics
Current age. Age was measured as a categorical variable with six categories, which
were collapsed prior to analysis into the following two categories: (1) 25-64; (2) 65 or older. The
cutoff threshold was selected because studies have shown significant differences in exposure to
financial hardship by age, in which individuals under 65 have greater risk of financial hardship
(Knight et al., 2018).
Race/Ethnicity. Race and ethnicity were measured as a mutually exclusive categorical
variable with the following seven categories: (1) African American; (2) Asian; (3) Hispanic; (4)
Pacific Islander; (5) White (not Hispanic); (6) Multi-racial; (7) other.
Gender. Gender was measured as a categorical variable with two categories: (1) female;
(2) male.
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Education. Education was measured as a categorical variable with seven categories. In
order to simplify data and improve interpretability of findings, these categories were collapsed
into two categories: (1) high school diploma or less; (2) some college or more.
Income. Income was measured as a categorical response to the following prompt, “What
was your total 2014 household income before taxes?” Response options are: (1) less than
$25,000; (2) $25,000 – $34,999; (3) $35,000 – $49,999; (4) $50,000 - $74,999; (5) $75,000 $99,999; (6) $100,000 - $149,999; (7) $150,000 or more; (8) Prefer not to answer. Only the first
seven responses were used in analyses. To improve the interpretability of analyses the income
variable was transformed to reflect 2015 Federal Poverty Guidelines for a family of four (U.S.
Department of Health and Human Services, 2015) so that the final variable contained four
categorical responses: (1) 150%FPL; (2) 150%-300% FPL; (3) 300%FPL – 600% FPL; (4)
600% FPL.
Domain 2: Behavioral
Patient activation was measured using the 10-item Patient Activation Measure (PAM), a
validated measure designed to assess individuals’ ‘self-concept as manager of their own health
needs’ (Hibbard & Gilburt, 2014, p. 8). The scale contains items related to health beliefs,
knowledge, skills and confidence. Higher scores indicate greater activation and can be coded and
analyzed as either continuous (scale of 0-100) or ordinal variables (1-4). See Table 2 for
frequency distribution of demographic variables.
Domain 3: Health Status
Cancer type. Cancer type was measured with a categorical response to the following
prompt, “what type of cancer were you most recently diagnosed with?” Response options
included: (1) bladder; (2) brain; (3) breast (early stage); (4) breast (metastatic); (5) colon or

23
rectal; (6) endometrial/cervical/ovarian; (7) head/neck; (8) kidney; (9) leukemia; (10) liver; (11)
lung; (l2) lymphoma; (13) melanoma; (14) myeloma; (15) pancreatic; (16) prostate; (17)
stomach; (18) thyroid; or (19) other.
Time since diagnosis. Time since diagnosis was measured with a categorical response to
the following prompt, “how long ago were you first diagnosed with cancer?” Response options
include: (1) within the last 12 months; (2) between 13 months and 2 years ago; (3) between 2
years and years ago; (4) more than 4 years ago.
Treatment status. Treatment status was measured with a categorical response to the
following prompt, “What is your current cancer status?” Response options include: (1) in active
treatment; (2) completed treatment and on maintenance; (3) completed treatment and not on
maintenance.
Work reduction. Employment changes related to cancer and its treatment were
measured with a categorical response to the following prompt, “What was your employment
status while you were being treated for cancer?” Response options included: (1) I continued
working full time; (2) I continued working part-time; (3) I switched from working full time to
part time; (4) I stopped working; (5) Does not apply, I was not working before receiving
treatment. For analyses, this item was transformed into a binary variable where categories 3 and
4 were collapsed to represent work hour reduction during treatment (yes/no). See Table 2 for
frequency distribution of health status variables.
Domain 4: Health System Factors
Insurance type. Insurance type was measured as a categorical, but not mutually
exclusive, response to the following prompt, “what type of health insurance do you have? Please
select all that apply.” Response options included: 1) commercial/private insurance through and
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employer, 2) private insurance via Healthcare.gov (the insurance exchange), 3)
Medicare/Medicaid, 4) private Medigap, 5) Tricare/Champus.
Estimated monthly out-of-pocket costs. Monthly out-of-pocket treatment costs were
measured using ordinal responses to the following prompt, “Thinking about the time when you
were getting cancer treatment, on average, how much did you spend (less than $100, $101-$250,
$251-$500, more than $500, don’t know) out of pocket each month on the following? Your best
estimate will do:” (1) co-payments and deductibles for drugs, doctor visits and tests; (2) nonprescription/OTC medications; (3) services to help with symptoms and side effects like
acupuncture or massage; (4) transportation to and from clinic visits, babysitting; (5) special
clothing, wigs, etc. Responses to the five items were averaged and scored as a single variable
ranging from 0-20, where higher scores represent higher estimated monthly out-of-pocket costs.
Difficulty anticipating out-of-pocket treatment costs. Difficulty anticipating treatment
costs, a measure of price transparency, was measured using responses to the following prompt, “
How difficulty or easy was it for you to determine the out-of-pocket cost of treatments before
you incurred the expense?” Ordinal response options were: (1) very difficult; (2) somewhat
difficult; (3) neither difficulty nor easy; (4) somewhat easy; (5) very easy. For analyses, this item
was transformed. Categories 1 and 2 were collapsed and a binary variable was created to
represent those who found out-of-pocket treatment costs to be somewhat to very difficulty to
anticipate (yes/no).
Ease of understanding insurance coverage. Understandability of insurance was
measured using reponses to the prompt, “how difficulty or easy is it for you to understand what
your insurance covers for your care” and treated as a continuous variable ranging from 1(very
difficult) to 5 (very easy). See Table 2 for frequency distribution of health system factors.
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Domain 5: Financial Hardship
Financial stress. Financial stress was measured using a single item, “To what degree has
your cancer treatment caused you financial hardship (i.e. difficulty paying your bills)?” Response
options included: (1) none; (2) a little; (3) some; (4) a lot; or (5) an extreme amount. For analyses
this ordinal variable was treated as a continuous variable where higher scores indicated greater
financial stress.
Financial strain. Financial strain, a measure of psychological distress attributed to
financial hardship, was measured using a single item, an ordinal measure of the degree of
psychological distress attributed to financial hardship. Respondents were asked, “Thinking about
a time when you were getting cancer treatment, how distressed (e.g. anxious, extremely upset)
were you from thinking about your finances? Response options included: (1) not at all distressed;
(2) a little distressed; (3) somewhat distressed; (4) very distressed or (5) extremely distressed.
For analyses this ordinal variable was treated as a continuous variable where higher scores
indicated greater strain.
Analytic Strategy
The following analyses were conducted by the Principal Investigator using StataIC
(version 15.1):
Aim 1
Exploratory factor analysis was conducted to identify the underlying dimensions of costcoping among the 32 cost-coping items. The items were first tested for factorability using
Bartlett’s test of sphericity and Kaiser Meyer-Olkin test (Tabachnick, Fidell, & Ullman, 2007).
Then, item distributions were tested for normality, which determined the appropriate extraction
method to use with the data. Because distributions were non-normal and some items were binary,
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Principle Axis Factor analysis (PAF) was used (Costello & Osborne, 2005). PAF is a common
method of exploratory factor analysis that measures correlations across multiple items to identify
underlying “factors.” Factors are highly correlated clusters of survey items which represent
underlying theoretical concepts or dimensions of a larger theoretical construct. Varimax rotation
was then used to minimize cross-loading of variables onto multiple factors, a rotation technique
that can be used to produce more distinct factors or dimensions (Tabachnick, Fidell & Ullman,
2007).
Aim 2
Analyses conducted in Aim 1 produced working measures of four distinct cost-coping
strategies. These measures were used as outcome variables in Aim 2 to predict variation in costcoping from social, behavioral and health system factors using logistic regression. Predictors for
each cost-coping strategy were grouped into five domains for the initial phase of model building:
(1) demographics (i.e. age, education, income, race/ethnicity, gender); (2) behavioral
characteristics (i.e. patient activation score); (3) health status (i.e. cancer type, time since cancer
diagnosis, treatment status, and work reduction due to illness); (4) health system features (i.e.
insurance type, difficulty anticipating out-of-pocket treatment cost, ease of understanding
insurance coverage, average monthly out-of-pocket costs); and (5) financial stress (i.e. cancerrelated difficulty paying bills). Logistic regression was determined to be most readily
interpretable statistical method for these data, so each outcome variable (i.e. care-altering,
lifestyle-altering, self-advocacy and financial help-seeking) was transformed into a binary
variable. Table 1 below presents a frequency table of the transformed binary outcome variables
used in Aim 2.
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A model predicting each coping strategy (care-altering, lifestyle-altering and selfadvocacy) was created for each of the five variable domains listed above. First, each independent
variable in the domain was tested in unadjusted models predicting each cost-coping outcome
using logistic regression (See Table 4 for independent predictor models). Those found to be
marginally significant (p < .05) were included in the domain model. Significant predictors in
each domain were retained and tested in adjusted models predicting care-altering, lifestylealtering and self-advocacy coping styles. Predictors that maintained significance in adjusted
models (p < .05) were included in the final predictive models of each cost-coping strategy.
For the purpose of conducting regression analyses, independent categorical variables with
multiple response options were either collapsed into two theoretically meaningful categories
(e.g., age was collapsed into two groups: 64 and under; 65 and over; education was collapsed
into two groups: high school education or less and some college or more) or transformed into
dummy variables where each categorical response was analyzed in the model as a binary variable
(e.g. cancer type, time since diagnosis and treatment status). Other ordinal variables were treated
as continuous because they could more easily be understood in terms of magnitude and behaved
as normally distributed variables. The two variables treated this way were financial stress (M =
2.43; SD = 1.28) and monthly out-of-pocket treatment costs (M = 7.31; SD = 4.84).
The following analyses were conducted by the Principal Invesigator using SPSS Statistics
(version 25):
Aim 3
In accordance with the Stress Process Model which suggests that coping can mediate or
moderate the relationship between stressors and stress outcomes, each coping variable was tested
in both possible roles. First, financial stress, strain and the cost-coping strategies were first tested
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for normality and transformed to meet assumptions of regression-based mediation and
moderation modeling. Then, in three separate analyses, Hayes’ PROCESS method of simple
mediation modeling (Hayes, 2012) was used to measure the mediated (direct and indirect) effect
of care-altering, lifestyle-altering and self-advocacy on the relationship between financial stress
and strain. To identify possible interaction effects between coping and financial stress in
predicting financial strain, the PROCESS method of simple moderation modeling was then used
on all three coping strategies to test for the significance and magnitude of each as conditional
variables (Hayes, 2012).
Permission and Human Subjects Review
I acquired written permission from CancerCare to use data from their Cancer Patient
Access and Engagement Study for my dissertation, as well as any presentations or publications
emanating from it (See Appendix 2).
Ethical Considerations
Because survey data were de-identified prior to analysis, CUNY Hunter College’s
Human Research Protection Program determined this study to be exempt from Institutional
Review Board review. The use of de-identified, existing data for the current study constitutes
minimal risk to participants. Procedures for informed consent were conducted by the researchers
responsible for data collection and respondents permitted CancerCare to use their de-identified
responses for the purposes of ongoing research as part of the informed consent process in the
original study. The de-identified data were stored in the Principal Investigator’s password
protected computer and all statistical analyses conducted on that computer at Silberman School
of Social Work, CUNY Graduate Center, or the PI’s home. Potential benefit to society was
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assumed to be much greater than the minimal risk associated with the use of this data for the
proposed study.
Table 1
Cost-coping Binary Outcome Variables
Survey Item

Yes-1

How often (never, did/do you do each of the following in order to
reduce your expenses related to your cancer treatment:

Rarely/
Never
Sometimes/Often
Always
409
101

Care-altering: (1) postpone or skip medical appointments; (2)
postpone or skip follow up testing; (3) postpone or skip
bloodwork; (4) postpone or skip filling a prescription; (5) delay or
skip complementary treatment; (6) postpone or skip psychological
support; (7) skip dosage of prescribed drugs; (8) cut pills in half;
(9) choose a lower cost medication; (10) order medication from
outside US
Self-advocacy: (1) estimate cost before going to ER; (2) estimate
cost before agreeing to treatment; (3) appeal a denial of benefit
from you insurance company; (4) estimate cost before filling a
prescription; (5) find out cost before filling a prescription for side
effects/symptoms; (6) review the explanation of benefits from
insurance company; (7) ask insurance company for help
understanding coverage; (8) find out cost of lab test or scans
before agreeing to testing
Financial help-seeking: (1) applied for co-payment assistance;
(2) applied for financial assistance for non-medical expenses; and
(3) applied for financial assistance through provider.
Which of the following have you experienced as a result of bills
related to your cancer treatment:
Lifestyle-altering: (1) I borrowed money from family/friends; (2)
I missed rent/mortgage payments; (3) I cut back on groceries,
transportation, clothing, tuition; (4) I missed paying bills like heat,
electricity, phone.

No-0

428

82

292

218

197

313
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CHAPTER V. FINDINGS
Sample Characteristics
The sample included 510 respondents ranging in age from 25 to 75 years old and over
half the respondents identified as female (64.7%). Most respondents identified their
race/ethnicity as White (70.8%), followed by African American (18.6%) and Hispanic (5.9%).
The majority of respondents had at least some college education (81.3%) and just over half
(59.5%) reported annual incomes under 300% FPL. Most respondents had health insurance
through their provider (64.5%) followed by Medicare/Medicaid (54.1%); health insurance
percentages total over 100 because categories were not mutually exclusive and some (17.5% )
respondents had multiple forms of insurance. The most common form of cancer reported was
early breast cancer (22.4%) followed by prostate (10.2%) and colorectal (8.0%). Most
respondents had been diagnosed over 4 years ago (44.3%) and had completed treatment (46.5%).
See Table 2 for complete sample characteristics.
Table 2
Sample Characteristics
Characteristic
Age (Years)
25-34
35-44
45-54
55-64
65-74
>75
Gender
Female
Male
Race/Ethnicity
African American
Asian
Hispanic
Pacific Islander
White

% (N= 510)

N

13.9
10.8
17.5
24.7
29.6
3.5

71
55
89
126
151
18

64.7
35.3

330
180

18.6
1.6
5.9
0.4
70.8

95
8
30
2
361

31
Characteristic
Multiracial
Other
Education
Less Than High School
High School Graduate (Or GED)
Some College
Associate’s Degree
Bachelor’s Degree
Master’s Degree
Doctorate/Professional Degree
Annual Income
150%FPL
150 %-300% FPL
300% - 600% FPL
>600% FPL
Insurance Type*
Private Through Employer
Private Through Healthcare.Gov
Medicare/Medicaid
Private Medigap
Tricare/Champus
Other
Multiple
Cancer Type
Bladder
Brain
Breast (Early)
Breast (Metastatic)
Colon Or Rectal
Endometrial, Cervical, Ovarian
Head / Neck
Kidney
Leukemia
Liver
Lung
Lymphoma
Melanoma
Myeloma
Pancreatic
Prostate
Stomach
Thyroid
Other (E.G. Esophageal, Intestinal,
Sarcoma/Bone, Sebaceous, Testicular)
Time Since Dx

% (N= 510)
2.0
0.8

N
10
4

1.4
17.5
22.4
10.6
30
14.9
3.4

7
89
114
54
153
76
17

25.5
34.0
34.6
6.0

123
164
167
29

64.5
9.0
54.1
11.2
4.1
5.7
17.5

181
46
276
57
21
29
89

3.5
2.2
22.4
6.5
8.0
6.7
1.8
4.9
4.7
0.4
5.3
3.7
2.6
0.8
2.4
10.2
0
4.9
8.8

18
11
114
33
41
34
9
25
24
2
27
19
12
4
12
52
0
25
45
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Characteristic
% (N= 510)
<12 Months
14.3
13 Months – 2 Years
20.0
2 – 4 Years
21.4
>4 Years
44.3
Treatment Status
In Active Treatment
20.2
Completed Treatment - On Maintenance
31.8
Completed Treatment
46.5
Work Change
Continued Working Fulltime
8.6
Reduced Work Hours
91.4
* Totals more than 100% because groups are not mutually exclusive

N
73
102
109
226
103
162
237
44
466

Aim 1: Identify measurable characteristics of cost-coping, and delineate working measures
of care-altering, lifestyle-altering and self-advocacy coping strategies.
The 32 items selected for analysis were determined to be highly factorable (Bartlett p
<.001, KMO=0.929). The principle axis factor analysis (PAF) with orthogonal varimax rotation
resulted in four factors with Eigenvalues over 1.0, accounting for 45%, 29%, 11% and 8% of
variance respectively. Examination of scree plot confirmed that a three- or four-factor structure
was most appropriate (See Figure 4). For the final cost-coping model, items with the highest
factor loadings from each factor were retained to produce an initial 25-item measure of costcoping (see Table 3 for a summary of the initial 25-item cost-coping measure).
The first three factors were well-aligned with the hypothesized conceptual dimensions of
care-altering, lifestyle-altering and self-advocacy cost-coping styles. The fourth factor that
emerged was unexpected, but is theoretically viable as it contained three items related to
financial help-seeking behavior, including: (1) applied for co-payment assistance; (2) applied for
financial assistance for non-medical expenses; and (3) applied for financial assistance through
provider. This factor was then tested as a coping strategy labeled Factor 4 “financial helpseeking” in Aims 2 and 3, findings are outlined below.
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Factor 1 was well-aligned with the concept of care-altering, the 10 items with factor
loadings over 0.65 retained for this dimension include “how often (never, rarely, sometimes,
often or always) did/do you do each of the following in order to reduce your expenses related to
your cancer treatment: (1) postpone or skip medical appointments; (2) postpone or skip follow up
testing; (3) postpone or skip bloodwork; (4) postpone or skip filling a prescription; (5) delay or
skip complementary treatment; (6) postpone or skip psychological support; (7) skip dosage of
prescribed drugs; (8) cut pills in half; (9) choose a lower cost medication; (10) order medication
from outside US?”
In Factor 2, items with factor loadings over 0.59 were retained. These 8 items were fairly
well-aligned with the hypothesized cost-coping dimension of self-advocacy. The items retained
for the self-advocacy domain include, “how often (never, rarely, sometimes, often, or always)
did/do you do each of the following…(1) estimate cost before going to ER; (2) estimate cost
before agreeing to treatment; (3) appeal a denial of benefit from you insurance company; (4)
estimate cost before filling a prescription; (5) find out cost before filling a prescription for side
effects/symptoms; (6) review the explanation of benefits from insurance company; (7) ask
insurance company for help understanding coverage; (8) find out cost of lab test or scans before
agreeing to testing.”
In Factor 3, items with factor loadings over 0.5 were retained. These 4 items were
conceptually well-aligned with the hypothesized cost-coping dimension of lifestyle-altering. The
4 items retained for the lifestyle-altering domain include “which of the following have you
experienced as a result of bills related to your cancer treatment (yes or no)… (1) I borrowed
money from family/friends; (2) I missed rent/mortgage payments; (3) I cut back on groceries,
transportation, clothing, tuition; (4) I missed paying bills like heat, electricity, phone.”
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Figure 4. Screeplot of eigenvalues indicating four factor solution
Aim 2: Identify behavioral, social and health system factors that predict variations in
coping.
The purpose of this analysis was to identify significant predictors of variations in costcoping identified in Aim 1: care-altering, lifestyle-altering, self-advocacy, and financial helpseeking. Special emphasis was placed on behavioral characteristics, social factors, and features
of the healthcare system. Independent predictors were similar across coping styles and variables
from every domain were significantly associated with each outcome. A full summary of the
independent predictors of each outcome are presented in Table 4.
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Table 3
Cost-coping Survey Items by Dimension
Cost-Coping Survey Items by Dimension

Factor

Factor Loading

How often (never, rarely, sometimes, often or always)
did/do you do each of the following in order to reduce
your expenses related to your cancer treatment:
(1) postpone or skip medical appointments

1

0.84

(2) postpone or skip follow up testing

1

0.85

(3) postpone or skip bloodwork

1

0.83

(4) postpone or skip filling a prescription

1

0.85

(5) delay or skip complementary treatment

1

0.70

(6) postpone or skip psychological support

1

0.75

(7) skip dosage of prescribed drugs

1

0.87

(8) cut pills in half

1

0.75

(9) choose a lower cost medication

1

0.82

(10) order medication from outside US

1

0.68

(11) estimate cost before going to ER

2

0.75

(12) estimate cost before agreeing to treatment

2

0.79

(13) appeal a denial of benefit from you insurance
company
(14) estimate cost before filling a prescription

2

0.54

2

0.84

(15) find out cost before filling a prescription for side
effects/symptoms
(16) review the explanation of benefits from
insurance company
(17) ask insurance company for help understanding
coverage
(18) find out cost of lab test or scans before agreeing to
testing
(19) applied for co-payment assistance;

2

0.81

2

0.58

2

0.64

2

0.81

4

0.51

(20) applied for financial assistance for non-medical
expenses
(21) applied for financial assistance through provider

4

0.56

4

0.56
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Cost-Coping Survey Items by Dimension

Factor

Factor Loading

Which of the following have you experienced as a
result of bills related to your cancer treatment
(yes/no):
(22) I borrowed money from family/friends

3

0.55

(23) I missed rent/mortgage payments

3

0.60

(24) I cut back on groceries, transportation, clothing,
tuition
(25) I missed paying bills like heat, electricity, phone

3

0.51

3

0.70

Predictors of Care-Altering
Of 510 respondents, 123 (24%) reported that they had never engaged in any of the 10
care-altering behaviors identified for this study, and another 218 (43%) reported that this
question was not applicable to their situation. The remaining 169 respondents (33%) reported
engaging in some form of this behavior at least once.
Demographics. When all independently significant demographic factors were accounted
for in a single model only age and income emerged as significant predictors of care-altering
Specifically, individuals under 65 years old had twice the odds of those over to 65 to report carealtering behavior, and individuals in the >150%FPL and 150%-300% FPL income brackets had
3.2 and 2.7 times the odds of those in the >600% FPL bracket respectively.
Behavioral. In unadjusted models, patient activation emerged as a significant predictor,
where lower activation scores were associated with care-altering behavior. Such that every unit
decrease in activation produced a 5% increase in the odds of care-altering.
Health status. Treatment status emerged as a significant predictor in the adjusted model
of the health status domain. Individuals in active and maintenance treatment for cancer had twice
the odds of those post-treatment to report care-altering.
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Health system factors. In the adjusted model of health system factors, high monthly out
of pocket medical costs, difficulty anticipating out-of-pocket costs and ease of understanding
insurance coverage emerged as a significant predictor of care-altering. Specifically, for every
unit increase in out-of-pocket costs there was a 13% increase in the odds of care-altering, those
who found it difficult to anticipate the out-of-pocket costs of treatments had twice the odds of
those who found it easy to anticipate, and for every unit increase in ease of understanding
insurance coverage there was a 30% reduction in odds of care-altering.
Financial stress. Higher levels of financial stress were associated with care-altering
such that every unit increase in perception of financial stress produced a twofold increase in the
odds of care-altering.
Predictors of care-altering: final model. When all of the significant predictors from
each domain were accounted for in the final model, monthly out-of-pocket costs (OR = 1.09, p <
.05), ease of understanding insurance coverage (OR = 0.73, p <.05) and financial stress (OR =
1.76, p <.001) significantly predicted care-altering behavior. The final model is presented in
Table 5. When accounting for other relevant variables, every unit increase in perception that
insurance coverage is easy to understand produced a 27% reduction in odds of care-altering,
while every unit increase in financial stress almost doubled the likelood of care-altering. Final
model of care-altering outlined in Table 6.
Predictors of Self-advocacy
Of 510 respondents, 82 (16%) reported that they never engaged in any form of selfadvocacy identified in this study. The remaining 428 (84%) engaged in self-advocacy at least
once. On a scale of 8-40, where 40 represents maximum engagement in self-advocacy, the
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average score was 17.8, indicating that although most of the respondents self-advocated on
occasion, most did not rely on self-advocacy intensively.
Demographics. Of the demographic variables, only age was significantly associated with
self-advocacy behavior such that individuals under 65 years old had 2.6 times the odds of
engaging in self-advocacy.
Behavioral. Patient activation was not significantly associated with self-advocacy.
Health status. After accounting for all the significant health status variables, in the
adjusted domain model only cancer type was a significant predictor of self-advocacy. Specifially,
individuals with thyroid cancer had 61% lower odds of engaging in self-advocacy compared to
individuals with other cancer types.
Health system factors. After accounting for all significant health system factors, high
monthly out-of-pocket medical costs and difficulty anticipating out-of-pocket treatment costs
were significantly associated with self-advocacy. For every unit increase in monthly out-ofpocket costs there was a 30% in crease in the odds of self-advocacy. Individuals who reported
difficulty anticipating out-of-pocket costs of treatment had 12 times the odds of engaging in selfadvocacy than those who did not perceive such difficulty.
Financial stress. Higher financial stress significantly predicted self-advocacy behavior
such that every unit increase in financial stress increased the odds of self-advocacy 2.5 times.
Predictors of self-advocacy: final model. In the fully adjusted model, cancer type,
monthly out-of-pocket costs, difficulty anticipating out-of-pocket treatment costs, and financial
stress predicted self-advocacy behavior. Specifically people with thyroid cancer had 89% lower
odds than individuals with other cancer types to engage in self-advocacy (OR = 0.21, p <.01).
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Table 4
Independent Predictors of Coping Strategy
Care-altering (n=292)

Self-advocacy (n=510)

%/
M (SD)

OR

SE

CI

OR

33%

2.32

0.49

1.53 - 3.52

2.64

48%

0.85

0.18

0.57 - 1.28

64%

1.07

0.23

25%
34%
35%
6%

2.77
2.60
1.80

18%
2%

SE

Lifestyle-altering (n=510)

Financial help-seeking
(n=510)

CI

OR

SE

CI

OR

SE

CI

0.65

1.63 - 4.27

4.44

1.02

2.84 - 6.96

3.72

0.73

2.53 - 5.48

1.30

0.32

0.81 - 2.10

0.58

0.11

0.41 - 0.84

0.66

0.12

0.46 - 0.94

0.71 - 1.64

1.45

0.35

0.90 - 2.36

1.93

0.38

1.31 - 2.85

1.00

0.18

0.69 - 1.45

1.21
1.10
0.75

1.17 - 6.54
1.14 - 5.95
0.80 - 4.06

0.97
1.45
1.92

0.46
0.74
0.99

0.36 - 2.64
0.54 - 3.92
0.70 - 5.28

4.57
3.31
2.55

2.39
1.71
1.32

1.64 12.76- 9.13
1.20
0.93 - 7.05

1.94
1.32
1.01

0.81
0.53
0.41

0.85 - 4.40
0.60 - 2.91
0.46 - 2.23

2.06
1.74

0.64
1.87

1.12 - 3.79
0.19 - 4.78

2.04
1.35

0.76
1.44

0.98 - 4.24
0.16 11.09

2.38
1.60

0.55
1.14

1.51 - 3.73
0.39 6.48

2.77
5.33

0.73
5.72

1.67 - 4.61
0.65 –
4.64

6%
71%

3.00
0.45

1.85
0.12

0.89 10.07- 0.74
0.27

0.95
0.59

0.48
0.35 - 2.57
0.17
0.33 - 1.04
Health Status

2.52
0.37

0.97
0.07

1.19 - 5.36
0.25 - 0.54

2.57
0.33

1.14
0.07

1.09 - 6.12
0.21 - 0
.50

14%
20%
21%
44%
9%

1.23
1.19
1.79
0.55

0.39
0.32
0.51
0.11

0.69 - 2.33
0.71 - 2.02
1.03 - 3.12
0.37 - 0.84

1.95
1.74
0.70
0.72
9.05

0.82
0.62
0.19
0.17
9.22

0.86 - 4.43
0.89 - 3.43
0.40 - 1.20
0.45 - 1.15
1.23 66.65

1.95
1.74
0.70
0.66
4.86

0.82
0.62
0.19
0.12
1.71

0.89 - 2.41
0.86 - 2.06
0.68 - 1.61
0.46 - 0.95
2.44 - 9.70

1.75
1.40
1.60
0.45
8.49

0.47
0.32
0.36
0.08
4.52

1.03 - 2.97
0.89 - 2.19
1.02 - 2.49
0.31 - 0.64
2.99 24.12

20%
32%
47%

1.64
1.55
0.52

0.46
0.35
0.11

0.94 - 2.86
0.96 - 2.40
0.35 - 0.79

1.77
1.96
0.44

0.61
0.57
0.11

0.89 - 3.47
1.11 - 3.46
0.27 - 0.71

1.67
2.08
0.35

0.37
0.40
0.07

1.08 - 2.58
1.42 - 3.04
0.24 - 0.51

2.35
1.71
0.36

0.57
0.34
0.07

1.46 - 3.77
1.16 - 2.52
0.25 - 0.52

4%
2%
22%

1.24
1.44
0.65

0.80
1.13
0.15

0.18 - 1.28
0.31 - 6.76
0.41 - 1.02

0.37
1.91
1.35

0.19
2.05
0.41

0.13 - 1.00
0.24 15.34- 2.46
0.74

0.78
2.89
0.88

0.40
1.80
0.18

0.29 - 2.13
0.82 - 9.85
0.53 - 1.27

0.59
7.69
0.68

0.28
8.10
0.15

0.23 - 1.51
0.98 60.57- 1.04
0.45

 Age

Under age 65
 Education

BA/BS

 Gender

Female
Income
150%
150-300
300-600
((600))
*Race / Ethnicity
African American
Asian
Hispanic
White
*First diagnosed
 12 months
13m – 2 years
2-4 years
>4 years
 Reduced work hours
*Treatment status
Active
Maintenance
Post
*Cancer type
Bladder
Brain
Breast (early)
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%/
M (SD)

Care-altering (n=292)

Self-advocacy (n=510)

Lifestyle-altering (n=510)

7%
8%
7%
5%
10%
5%

OR
1.85
1.34
1.46
3.65
0.56
2.95

SE
1.00
0.55
0.73
2.72
0.17
2.20

CI
0.59 - 3.63
0.62 - 2.98
0.31 - 1.04
0.85 15.73-1.04
0.30
0.57 - 5.07

OR
SE
CI
1.41
0.78
0.48 - 4.15
1.12
0.52
0.46 - 2.78
1.47
0.80
0.50 - 4.29
1.35
0.70
0.32 - 2.87
0.53
0.18
0.27 - 1.05
0.38
0.17
0.16 - 0.92
Health System Factors

OR
2.28
0.91
2.12
1.63
0.35
1.77

SE
0.83
0.31
0.76
0.68
0.13
0.73

CI
1.11 - 4.66
0.47 - 1.76
1.05 - 4.28
0.72 - 3.70
0.17 - 0.70
0.79 - 3.97

Financial help-seeking
(n=510)
OR
SE
CI
1.33
0.49
0.64 - 2.77
2.15
0.78
1.05 - 4.40
1.39
0.52
0.68 - 2.89
2.32
1.11
0.91 - 5.95
0.43
0.13
0.24 - 0.77
0.80
0.33
0.36 - 1.79

Private
Marketplace
Medigap
Medicare/caid
Multi
Other
Monthly out-ofpocket health costs
(0-20)
Easy to understand
insurance coverage
(1-5)

36%
9%
11%
54%
18%
6%
7.3 (4.8)

0.78
1.56
1.55
0.75
0.72
1.23
1.15

0.17
0.63
0.56
0.16
0.19
0.58
0.03

0.51 - 1.17
0.71 -3.45
0.76 - 3.19
0.50 - 1.14
0.44 - 1.21
0.49 - 3.10
1.09 - 1.21

1.61
2.94
1.44
0.43
1.14
1.21
1.35

0.43
1.79
0.60
0.11
0.37
0.67
0.06

0.95 - 2.73
0.89 - 9.72
0.62 - 3.24
0.26 - 0.72
0.60 - 2.18
0.41 - 3.57
1.23 - 1.47

0.84
1.66
1.17
0.72
0.73
0.43
1.12

0.16
0.52
0.52
0.13
0.13
0.12
0.02

0.57 - 1.22
0.91 - 3.06
0.67 - 2.06
0.51 - 1.04
0.26 - 0.73
0.20 - 1.16
1.08 - 1.16

0.74
1.61
1.44
0.70
0.55
1.24
1.20

0.14
0.53
0.42
0.13
0.13
0.49
0.03

0.51 - 1.07
0.84 - 3.06
0.81 - 2.55
0.49 - 0.99
0.35 - 0.87
0.57 - 2.67
1.14 - 1.26

3.5 (1.1)

0.61

0.07

0.50 - 0.76

0.62

0.08

0.48 - 0.79

0.73

0.06

0.62 - 0.86

0.73

0.06

0.62 - 0.87

 Difficult

26.3

2.93

0.85

1.66 - 5.18

17.84

12.91

4.32 73.65

3.01

0.62

2.00 - 4.52

1.76

0.37

1.17 - 2.66

1.89 - 3.27

3.26

0.35

2.65 - 4.02

2.10

0.18

1.78 - 2.49

0.91 - 1.00

0.96

0.02

0.93 - 0.99

0.93

0.02

0.91 - 0.97

Breast (meta)
Colorectal
Female repro
Leukemia
Prostate
Thyroid
*Insurance type

to
anticipate OOP cost
of treatment

Financial Stress
Financial stress [1-5]

2.4 (1.3)

2.10

0.22

1.71 - 2.58

2.49

0.35
Behavioral

PAM [0-40]

32.4
(5.9)

0.95

0.02

0.91 -0.99

0.96

0.02
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Every unit increase in monthly out-of-pocket costs (OR = 1.27, p < .001), and financial stress
(OR = 1.89, p < .001) increased the odds of self-advocacy by 27% and 89% respectively. People
who found in difficult to anticipate the out-of-pocket costs of their treatment had 12 times the
odds of engaging in self-advocacy (OR = 12.10, p < .001). The final model is presented in Table
5.
Predictors of Lifestyle-Altering
Of 510 respondents, the majority (61.4%, n=313) did not report having engaged in
lifestyle-altering activities in response to cancer treatment costs. Another 25% (n=125) reported
at least one lifestyle-altering event, while 19 individuals endured all four major lifestyle-altering
events.
Demographics. Among demographic variables, age, gender, race/ethnicity, and
household income emerged as significant predictors of lifestyle-altering in independent and
adjusted domain models. Individuals under 65 years old had 3.7 times the odds of lifestylealtering than older adults, women had 1.9 times the odds of men, people in the <150% FPL
income bracket had twice the odds of those in the highest income bracket to engage in carealtering. People identifying as White had 60% lower odds than non-White respondents of
experiencing lifestyle-altering.
Behavioral. Lower patient activation level was marginally associated with lifestyle
altering in independent models such that every unit increase in activation reduced the odds of
lifestyle-altering by 5%.
Health status. After accounting for all significant predictors of lifestyle-altering in the
health status domain, employment changes and cancer type remained significant. Individuals
who reported reduced work hours during treatment had 3.3 times the odds of experiencing
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lifestyle-altering. People with cancers of the female reproductive system had 2.4 times the odds
and individuals with prostate cancer had 60% lower odds of experiencing lifestyle-altering.
Health system factors. Among factors related to the health system, insurance coverage,
monthly out- of-pocket costs, and difficulty anticipating treatment costs were significantly
associated with lifestyle-altering in the domain adjusted model. Having multiple forms of
insurance reduced the odds of lifestyle-altering by 53%, while every unit increase in monthly
out-of-pocket costs increased lifestyle -altering by 10%. Individuals who found it difficulty to
anticipate treatment costs had 2.6 times the odds of lifestyle-altering.
Financial stress. For every unit increase in reported financial stress the odds of lifestylealtering increased 3.3 times.
Predictors of lifestyle-altering: final model. In the final adjusted model, gender,
race/ethnicity, financial stress and difficulty anticipating treatment costs were significant
predictors of lifestyle-altering. Women had twice the odds of men (OR = 2.00, p < .01), and
White people had half the odds of those identifying as another race/ethnicity (OR = 0.50, p <.05)
of lifestyle-altering in response to treatment costs. Those who found it difficult to anticipate
treatment costs had almost twice the odds of lifestyle altering than those who did not (OR = 1.85,
p < .05), and every unit increase in financial stress increased the odds of lifestyle-altering
threefold (OR =2.90, p < .001). The final model is presented in Table 5.
Predictors of Financial Help-Seeking Behavior
Of 510 respondents, 218 had never engaged in financial help-seeking, while another 87
felt that this question was not applicable to their experience. The remaining 203 individuals
(39.8%) engaged in some form of financial help-seeking activity at least once.
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Demographics. In the domain adjusted demographics model only age and ethnicity were
significantly associated with financial help-seeking. Individuals under 65 had almost three times
the odds of engaging in financial help-seeking than those over 65 and individuals identifying as
white had 58% lower odds of financial help-seeking.
Health status. Among variables related to health status, employment changes and cancer
type were significantly associated with financial help-seeking. Individuals who experienced
reduced work hours had nearly six times the odds of seeking out financial assistance and
individuals with prostate cancer had nearly half the odds of those with other cancers.
Behavioral. Higher patient activation scores increased the odds of financial help-seeking
such that unit increase in patient activation score odds of financial help seeking decreased the
odds of financial help-seeking by 6%.
Health system factors. Among health system factors understandability of insurance
coverage and monthly out-of-pocket treatment costs were associated with financial help-seeking.
For every unit increase in understandability of insurance coverage odds of financial help-seeking
decreased by 19%. Similarly for every unit increase in monthly out-of-pocket costs the odds of
financial help-seeking increased by 20%.
Financial stress. Financial stress was significantly associated with financial helpseeking behavior such that every unit increase in difficulty paying bills due to cancer doubled the
odds of financial help seeking.
Predictors of financial help-seeking: final model. In the fully adjusted model of all five
domains, financial help-seeking was significantly predicted by age, patient activation score,
financial stress and high monthly out-of-pocket treatment costs. Individuals under 65 years old
were almost twice as likely to engage in financial help-seeking (OR = 1.63, p < .001), and for
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every unit increase in patient activation the odds of financial help-seeking decreased by 5% (OR
= 0.95, p <.05). For every unit increase in financial stress the odds of financial help-seeking
nearly doubled (OR = 1.57, p <.001) and for every unit increase in monthly out-of-pocket
medical costs the odds of financial help-seeking increased 10% (OR = 1.10, p <.001). The final
model of financial help-seeking is presented in Table 5.
Table 5
Final Models Predicting Each Cost-coping Strategy

Predictors of Care-Altering: Final Model
Predictors
OR
SE
95% Confidence Interval
Monthly OOP [0-20]
1.09
0.04
1.06 - 1.22
Financial stress [1-5]
1.73
0.22
1.40 - 2.22
Ease of understanding insurance [1-5]
0.73
0.09
0.57 - 0.92

P
<.001
<.001
<.01

Predictors of Self-Advocacy: Final Model
Predictors
OR
SE
95% Confidence Interval
Monthly OOP [0-20]
1.27
0.06
1.16 - 1.34
12.09
8.51
2.83 – 51.60
Difficult to anticipate tx cost
Financial stress [1-5]
1.89
0.31
1.37 - 2.47
*Thyroid cancer
0.21
0.12
0.07 - 0.67

P
<.001
<.001
<.001
<.01

Predictors of Lifestyle-Altering: Final Model
Predictors
OR
SE
95% Confidence Interval
2.00
0.53
1.32 - 3.48
Gender (female)
*Race/Ethnicity (White)
0.50
0.14
0.29 - 0.86
1.85
0.51
1.07
– 3.15
Difficult to anticipate tx cost
Financial stress [1-5]
2.90
0.37
2.49 - 3.85

P
<.05
<.05
<.05
<.001

Predictors of Financial Help-Seeking: Final Model
Predictors
OR
SE
95% Confidence Interval
1.63
0.37
1.17-2.99
Age (under 65)
Patient Activation Score
0.95
0.02
0.91-0.99
Financial stress [1-5]
1.67
0.16
1.38-2.03
Monthly OOP [0-20]
1.10
0.03
1.07-1.20
*Categorical dummy variable compared to members of all other categories;
Binary variable compared to null option;
OOP refers to out-of-pocket costs

P
<.001
<.05
<.001
<.001
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Aim 3: Analyze quantitative survey data to measure the extent to which each cost coping
strategy mediates and/or moderates the relationship between financial stress and strain.
Correlations. Highly significant, positive correlations were found between financial
stress and strain (r = 0.63, p < .001), financial stress and care-altering (r = 0.56, p < .001),
financial stress and lifestyle-altering (r = 0.59, p < .001), and financial stress and self-advocacy
(r = 0.49, p < .001). Similarly significant correlations were found between financial strain and
care-altering (r = 0.43, p < .001), financial strain and lifestyle-altering (r = 0.47, p < .001), and
financial strain and self-advocacy (r = 0.39, p < .001).
In order to test the overall fit of the hypothesized mediation and moderation models
Hayes’ PROCESS method (specifically Models 1 and 4) was employed. First, variables were
tested for normality and transformed to meet assumptions of linear regression. The distributions
of each of the three coping variables were found to be zero-inflated. As such, the null responses
in care-altering, lifestyle-altering and self-advocacy were dropped from analyses in order to
comply with the assumption of normality required for regression-based analyses. Removing the
null responses did not significantly reduce statistical power, and it also made more sense
conceptually to measure the extent of mediation and moderation using responses that affirmed
some cost-coping behavior. Descriptions of each variable are presented in Table 6.
Mediation. Simple mediation models using the PROCESS method (Model 4) were
implemented testing care-altering, lifestyle-altering, self-advocacy and financial help-seeking
coping strategies as independent mediators of financial stress’ impact on financial strain. Model
results indicated the presence of a significant mediating effect for lifestyle-altering only (p <
.05). The a path was significant, such that financial stress was positively associated with
lifestyle-altering (B = 0.43, p < .001). As were the c (B = 0.54, p < .01) and c’ (B = 0.46, p < .01)

47
paths which show the total and direct effect of stress on strain.Lifestyle-altering accounted for a
small but significant indirect effect of stress on strain (B = 0.08, p < .05). This finding suggests
that financial stress may increase strain via lifestyle-altering. See Figure 5.
Table 6
Descriptive Summary of Variables Tested for Mediation/Moderation
Variable
Financial Stress
Financial Strain
Care-altering#
Lifestyle-altering#
Self-advocacy#
Financial help-seeking#
#Null responses removed

N
510
510
168
197
428
205

Range
[1-5]
[1-5]
[11-50]
[1-4]
[9-40]
[4-15]

M
2.43
2.53
23.44
1.69
21.14
8.54

(SD)
1.28
1.26
10.24
1.02
7.35
3.11

Moderation. Moderation models using the PROCESS method (Model 1) to identify the
presence of significant and independent interaction effects between financial stress and each of
the constructs of interest, care-altering, lifestyle-altering and self-advocacy coping styles
respectively. Results indicated that only self-advocacy yielded a significant interaction effect
with financial stress in predicting financial strain. The main effect of self-advocacy on financial
strain was significant and positive (B = .05, p < .05), while the interaction effect of self-advocacy
and financial stress was significant and negative (B = -.01, p < .01). Suggesting that selfadvocacy may dampen the effect of financial stress on strain. See Figure 6.
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Figure 5. Simple mediation model with lifestyle-altering as mediator

Figure 6. Relationship between stress and strain moderated by self-advocacy
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Post-Hoc Analyses
While completing the analyses, an issue emerged that called for post-hoc analyses. In
Aim 2, financial stress was a significant independent predictor of all coping outcomes. When
financial stress was added to the final models, relationships between variables from other
domains and the outcome variables were either diminished or rendered inert across all four
coping outcomes. Financial stress is a powerful downstream indicator of all four coping
strategies and it could be a clinically useful measure. In order to hone in on more upstream
determinants of financial toxicity post-hoc analyses were conducted to model significant
predictors of financial stress.
Post-hoc Analysis Methods
The same methods of modeling the cost-coping outcomes in outlined Aim 2 were used to
model significant predictors of financial stress. I determined that logistic regression would yield
the most readily interpretably results for this research question. As such, the outcome variable,
financial stress, was modified from an ordinal (1-5) to a binary variable (0-1). The ordinal
financial stress measure was recoded in such a way that responses to the question “To what
degree has your cancer treatment caused you financial hardship (i.e. difficulty paying your
bills)?” were coded as “1” if the response was “a little,” “some,” “a lot,” or “an extreme amount”
and coded as “0” if the response was “none.” Step-wise logistic regression was then performed
using the variables from four predictor domains – (1) demographics; (2) behavioral; (3) health
status; and (4) health system factors. Each predictor domain was modeled with the binary
financial stress outcome to identify significant predictors from each domain. The signficant
predictors from each domain were reserved and tested in a final, multi-domain model of financial
stress.
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Post-hoc Analysis Findings: Predictors of Financial Stress
Demographics. Age, income, and race/ethnicity were significant predictors of financial
stress in the adjusted domain model. Individuals under 65 years old were nearly six times more
likely than those over 65 to experience financial stress, individuals in the <150% FPL and 150%300% FPL income brackets were 2.9 and 2.2 times more likely to report financial stress than
those in the >600%FPL bracket. White respondents were half as likely as non-White respondents
to report financial stress.
Behavioral. Activation scores were independently associated with financial stress, for
every unit increase in activation score the odds of financial stress decreased by 5%.
Health status. Among health status variables, employment change, cancer type and time
since diagnosis emerged as significant predictors of financial stress both independently and in
adjusted domain models. Individuals with reduced work hours were seven times more likely to
report financial stress than those who did not work less, those diagnosed in the last 12 months
were two times more likely to experience financial stress than those diagnosed more than 12
months ago, and those with early breast cancer and prostate cancer had approximately half the
the odds of those with other cancer types.
Health system factors. Among health system factors, monthly out of pocket costs,
insurance type, ease of understanding insurance and difficulty anticipating out-of-pocket costs
were significantly associated with financial stress in the adjusted domain model. Specifically,
every unit increase in monthly OOP costs increased the odds of financial stress by 25%; having a
plan purchased on the Affordable Care Act marketplace increased the odds of financial stress 2.3
times; difficulty anticipating treatment costs increased the odds of financial stress 2.5 times; and
ease of understanding insurance coverage decreased the odds of stress by 23%.
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Table 7
Predictors of Financial Stress
Predictors of Financial Stress: Final Model
OR
SE
95% Confidence
3.15 0.86
2.05 - 5.57
Interval
0.44 0.12
0.26 - 0.77

Predictors
Age (under 65)
*Race/Ethnicity
Income ((>600% FPL)
(White)
<150% FPL
5.18 1.90
2.52 - 10.65
150% - 300% FPL
2.69 0.87
1.42 - 5.06
4.21
2.57
1.28
- 13.90
Reduced work hours
*Diagnosed in last 12 months
2.09 0.71
1.07 - 4.07
Monthly OOP [0-20]
1.21 0.04
1.10 - 1.24
Ease of understanding insurance coverage
0.76 0.08
0.57 - 0.89
1.90 0.48
1.01 - 3.01
Difficult to anticipate OOP cost of
[1-5]
*Categorical dummy variable compared to members of all other categories
treatment
Binary variable compared to null option

P
<.001
<.01
<.001
<.01
<.05
<.05
.<.001
<.01
<.05

Predictors of financial stress: final model. In the final adjusted model, age, income,
race/ethnicity, reduced work hours, monthly out-of-pocket medical costs, time since diagnosis,
difficulty anticipating out-of-pocket treatment costs and ability to understand insurance coverage
predicted financial stress. Specifically, those under 65 years old were three times more likely to
report financial stress than those over 65 (OR = 3.15, p <.001). White respondents were half as
likely as non-Whites (OR = 0.44, p <.001) to report stress, and those with annual household
incomes <150% FPL (OR = 5.18, p < .001) and 150%-300% FPL (OR = 2.69, p <.001) were five
and three times more likely to report financial stress than those in the >600% FPL bracket.
People who reduced work hours were four times more likely to report financial stress than those
who had not reduced work hours (OR = 4.21, p<.05). Individuals diagnosed in the last 12
months had twice the odds of those diagnosed more than 12 months ago (OR = 2.09, p <.05). For
every unit increase in monthly out-of-pocket costs, the odds of financial stress increased by 20%
(OR = 1.20, p <.001). Those who found it difficult to anticipate out-of-pocket treatment costs
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were almost twice as likely to report financial stress (OR = 1.89, p < .05). For every unit
increase in ease of understanding insurance coverage the odds of financial stress decreased by
23% (OR = 0.77, p < .05). The final model predicting financial stress is presented in Table 7.
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CHAPTER VI. DISCUSSION
The overall goal of this dissertation is to advance knowledge of the coping strategies that
insured cancer patients and survivors use to balance the financial needs of their household with
the direct and indirect costs of having cancer. This exploratory study aimed to develop a model
of financial hardship and coping that can be used to identify modifiable behavioral and social
factors associated with successful coping (i.e. coping that reduces psychological distress). In
doing so, we hoped to generate testable hypotheses on social and psychological aspects of costcoping, and contributes to the theoretical knowledge of financial hardship as a social determinant
of health. This section offers interpretations of the study findings and possible future directions
in light of the current literature on financial toxicity and the methodological limitations of the
study. suggest that the goals and aims were effectively achieved.
Exploratory factor analysis revealed a four factor solution for items related to cost-coping
in a survey of cancer patients and survivors. Each factor aligned to a hypothesized problemfocused coping strategy and were given the following concept labels: care-altering, lifestylealtering, self-advocacy and financial help-seeking. Two of these factors identified were wellaligned with measures of lifestyle-altering and care-altering used in past studies (Nipp et al.,
2016; Zullig et al., 2013). The first dimension identified in the factor analysis comprised ten
items that are highly consistent with the unvalidated survey items used to measure care-altering
in a study conducted by Nipp and colleagues (2016). The second cost-coping strategy identified,
lifestyle altering, was narrowed down to four items – (1) borrowing money from friends and
family, (2) missing rent/mortgage payments, (3) missing essential utility payments, and (4)
cutting back spending on groceries, transportation, clothing and/or tuition. Despite minor
differences, this categorization is well-aligned with the unvalidated measures of lifestyle-altering
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used in external studies (Nipp et al., 2016; Zullig et al., 2013). Additionally, two factors emerged
that have not yet been explicitly measured in the context of cancer financial toxicity: selfadvocacy and financial help-seeking.
The third cost-coping strategy consisted of eight survey items that are best described
using the term financial self-advocacy, but specifically measure the actions people took to
prepare for medical costs before agreeing to a treatment. These items reflect a certain level of
knowledge about how the fee-for-service health care system operates. Although self-advocacy
has been promoted as a necessary skill for cancer patients and survivors (Hagan & Donovan,
2013; Walsh-Burke & Marcusen, 1999), it has not been well-studied in relation to cancer-related
financial behaviors and responses to financial hardship.
The fourth dimension of cost-coping emerged unexpectedly. It contained three items
related to asking for financial and copayment assistance from treatment providers and non-profit
organizations which seemed to describe financial help-seeking. There is very little empirical
research on financial help-seeking and the role of financial assistance programs in reducing
financial stress and toxicity. The proportion of cancer patients in the general population seeking
financial assistance is uncertain, however nearly 40% of the respondents in this relatively study
reported reaching out to various patient financial assistance programs for help with their medical
bills. The limited number of studies in this area suggest a lack of transparency and consistency in
patient financial assistance programs (Zafar, Peppercorn, Asabere, & Bastian, 2017), and the
possiblility that they increase overall drug costs and reinforce existing cancer health disparities
(Zafar & Peppercorn, 2017; Zullig, Wolf, Vlastelica, Shankaran, & Zafar, 2017). More research
should be conducted on this important, heavily relied upon aspect of the cancer support network.
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Together, these findings suggest that there are at least four distinct behavioral responses
to financial stress in cancer, however further research is needed to validate this measure and the
underlying concepts. Past studies on financial toxicity have largely emphasized two cost-coping
strategies: care-altering and lifestyle-altering (Nipp et al., 2016; Zullig et al., 2013). Findings
from this study lend empirical support to the unvalidated measures of care-altering and lifestylealtering used in those studies. Findings from this study go on to suggest two additional costcoping behaviors: self-advocacy and financial help-seeking. There is little research on these two
coping strategies in the literature on financial toxicity in cancer and more should be conducted to
understand their role in containing or proliferating financial toxicity.
These four coping strategies were found to vary somewhat by social, behavioral and
health system factors, but seemed to have more commalities than differences. Findings shed light
on a number of common predictors of cost-coping. Financial stress, measured here as “difficulty
paying one’s bills due to cancer,” was a strong predictor of all four strategies. High monthly outof-pocket costs, difficulty anticipating out-of-pocket treatment costs or understanding what was
covered by one’s health insurance were also important predictors. Financial stress was such a
strong common predictor that post hoc analyses were conducted to identify factors associated
with financial stress. These were found to be age (being younger than 65), race/ethnicity
(identifying as non-White), income (annual household income  300% FPL), reducing work
hours due to cancer, high monthly out-of-pocket costs and difficulty understanding insurance or
anticipating out-of-pocket costs. Differences in the measurement of financial stress make it
difficult to link this finding perfectly to those of past studies, however a 2017 systematic review
conducted by Gordon et al. identified the following determinants of financial stress among 25
studies: identifying as female, African American or Hispanic, younger age, low income or
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reduced work hours, and having high out-of-pocket costs or no health insurance. Results from
the current study lend support to those of past studies and go on to suggest that the
understandability and interpretability of insurance coverage may also play a role in financial
stress and cost-coping.
Findings shed light on the cost-coping processes of cancer patients and survivors and
contribute to the literature on the structural basis of exposure to cancer-related financial stress. It
was determined that only two cost-coping strategies played meaningful roles in the relationship
between financial stress (i.e. difficulty paying one’s bills due to cancer) and financial strain (i.e.
psychological distress attributed to cancer-related financial hardship), and could therefore be
implicated in the stress process. Lifestyle-altering was found to significantly mediate (B = 0.08, p
< .05) the positive, linear relationship between stress and strain, explaining its effect. One the
other hand, self-advocacy was found to interact significantly (B = -0.01, p < .01) with financial
stress to buffer its effect on financial strain.
The individuals most likely to report lifestyle-altering experiences in this sample were
women, individuals identifying as non-White, and those who experience reduced employment
during cancer treatment. Lifestyle-altering was the only strategy explored in this study that was
significantly associated with gender, race/ethnicity in fully-adjusted models. These findings
contribute to the growing evidence on race- and gender-based disparities in cost-coping. For
example, in a large sample of women with a history of breast cancer Jagsi and colleagues (2015)
found that racial and ethnic minorities were more likely to endure both care- and lifestylealtering experiences, which they called privations. In light of these findings, the term privation
may be preferable to lifestyle-altering because it more accurately captures the distress that these
experiences can cause. Furthermore, its role in proliferating financial stress via mediation may be
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sufficient reason to rethink labeling it as a “coping strategy.” There is limited research on the
experiences of people who experience privations and life alterations related to cancer treatment
cost. Future studies should explore the situational contexts and decision making processes
involved in lifestyle-altering to better understand how these outcomes can be averted.
These findings point to a meaningful inequity in the health system in which women,
people of color and individuals without adequate employment protections are more likely to
seriously alter their lifestyles to accommodate the cost of their treatment in ways that pose a
threat to their mental health and wellbeing. These results are consistent with the literature on
cancer health disparities in suggesting that these populations may be unduly burdened, materially
and psychologically, by inefficiencies in the current American health care system. (Glanz,
Croyle, Chollette, & Pinn, 2003).
Study Limitations
As a secondary analysis of survey data this study has certain limitations that should guide
interpretation of these findings. Because 3000 invitation emails were sent, the final sample of
511 represents a 17% response and inclusion rate. This accounts for individuals who were ruled
out because they did not have a history of cancer, were under 25 years old, or did not have health
insurance. The remaining were self-selected to participate in an online survey which limited the
sample to individuals who engage in market research with access to the internet. The result was a
sample distribution that should be considered marginally representative of the U.S. population of
cancer patients and survivors, where only 78% of the population has access to a home computer
with broadband internet access (U.S. Census Bureau, 2017). Further, since the survey was only
provided in English, findings should not be generalized to individuals who do not read English.
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Similarly, some individuals may have been too fatigued or seriously ill to participate, these
findings cannot be thought to represent that subpopulation of cancer patients.
In addition to being reliant on self-report, another limitation of this study is that measures
of cost-coping, stress, and strain were not validated instruments. This is because the survey was
originally designed to collect in-depth descriptive data on American cancer patients and
survivors and was not aimed at testing correlational or causal relationships. Many variables were
categorical or ordinal where continuous measures would have allowed for more granular
analyses. For example, a more precise measure of objective financial stress could have been
generated using a ratio of annual household income to monthly out-of-pocket expenses if these
data points had been collected using continuous rather then ordinal/categorical response options.
Further, if data on household size and marital status had been collected, analyses using annual
household income would have been interpreted more effectively. In light of these limitations,
findings should be considered exploratory rather than conclusive, suggesting areas for further
exploration and serving to generate hypotheses and research questions for future studies.
Implications for Policy
Findings suggest that cancer-related financial stress represents a significant psychosocial
burden that affects several vulnerable populations that social workers serve. Women, people of
color, the poor and underinsured are unduly burdened by the material and psychological costs of
cancer treatments. Cancer patients, especially those from traditionally marginalized backgrounds,
would benefit from guaranteed access to high-quality insurance plans with minimal or zero costsharing requirements.
The importance of health insurance type and quality in predicting financial stress was
seen in findings throughout this study. Bivariate analyses in this study showed that having
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Medicare or Medicaid insurance coverage reduced the risk of engaging in lifestyle-altering and
financial help-seeking strategies. Younger patients and survivors, specifically those under 65
years old and therefore not qualifying for Medicare, were more likely to report financial stress.
This has been found repeatedly in past studies (Banegas et al., 2016; Shankaran & Ramsey,
2015; Yabroff et al., 2015; Zafar et al., 2013) and has been attributed, at least in part, to the
protective effect of Medicare for older adults (Yabroff et al., 2015). Further, individuals
reporting household annual incomes 300% above the federal poverty line were more likely to
report financial stress. Despite living just above the poverty line, people who earn above 138%
FPL are not eligible for Medicaid in many states and must rely on either employer-sponsored or
Marketplace insurance plans, which vary greatly in cost-sharing requirements (Buttorff,
Andersen, Riggs, & Alexander, 2015; Graves & Mishra, 2016; Thorpe, Allen, & Joski, 2015). As
a possibly remedy to underinsurance and financial stress, policy makers have been exploring the
expansion of public insurance options through Medicare (Friedman, 2013) or Medicaid
(Wikelius & O’Toole, n.d.).
Factors related to the understandability of insurance and ability to anticipate out-ofpocket costs were also important in predicting financial stress and cost-coping. Health service
researchers are exploring the utility of price transparency tools and cost of care discussions for
reducing health care spending, but at this time there is limited evidence that cancer patients and
survivors will benefit from these interventions (Henrikson & Shankaran, 2016; Shih, Nasso, &
Zafar, 2018; Sinaiko & Rosenthal, 2016). Furthermore, although it’s generally a good idea to
understand the details of one’s health insurance coverage, there is limited evidence to suggest
that health insurance literacy reduces financial stress in cancer. In fact there is some evidence
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that the effort needed to access and understand health insurance and cost information is highly
burdensome for cancer patients and survivors (George, Grant, James, Mir, & Politi, 2018).
Implications for Practice
In the absence of a robust policy response, clinical interventions are needed to bolster
effective coping and to target material resources and psychological support where they are most
beneficial. Clinical programs aimed at reducing financial hardship should be adapted to reflect
emerging distinctions in coping style. Social workers and other psychosocial oncology providers
need the tools to (1) identify individuals at risk for financial stress and (2) identify individuals
using risky or distressing coping strategies like care-altering and some life-altering behaviors.
Providers will then be prepared to deliver targeted psychosocial support that can include material
or specialized behavioral interventions.
This study outlined important predictors of financial stress and coping that might be
useful as clinical indicators of patients at risk of financial toxicity. As stated previously, certain
patient populations may be at greater risk. These include women, people of color, those with
annual household incomes below 300% FPL (< $75,000 / year ) and individuals with high
deductible insurance plans who are likely to incur high out-of-pocket costs related to treatment.
Financial stress can be measured by the question “have you had difficulty paying your bills due
to cancer treatment?” These indicators can be used to inform the development of screening tools
for the early identification of financial toxicity in clinical practice.
This study highlighted the benefits of financial self-advocacy, a coping strategy shown to
decrease financial strain/distress. Oncology social workers and financial navigators can teach
self-advocacy skills, help people make sense of their coverage and plan appropriately for the outof-pocket costs of treatment. As such, these findings may inform the development of evidence-
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based patient-education, screening and decisional support tools that support optimal problem and
emotion focused coping.
Implications for Research
To date, few studies have examined the ways that people cope with treatment-related
financial stress. Future research would benefit from the development of a valid and reliable scale
of cost-coping. The preliminary measure developed in this dissertation offers a beginning for
developing such a scale. In this study, however, only problem-focused coping strategies were
identified. Recent studies have begun to identify other coping strategies that should be explored
in greater depth and adequately measured (Head et al., 2018). In particular, emotion-focused
coping and social support may have positive impacts on health and mental health outcomes in
financially burdened cancer patients that deserve greater attention.
Financial help-seeking emerged as a distinct strategy for a large subset of respondents in
this study. In general, financial assistance programs have not been well-examined in the
scholarly literature despite the reliance of them in clinical practice. Support for the effectiveness
of financial assistance programs has been largely anecdotal, suggesting a need for more
extensive evaluation studies. The universe of cancer financial assistance programs should be
mapped out to better understand how these programs can be optimized to meet the growing
financial needs of cancer patients and to target subpopulations more precisely.
Conclusion
This dissertation sought to (1) identify distinct problem-focused coping strategies by
testing the underlying factor structure of commonly used measures of cost-coping; (2) model the
social, behavioral and health system factors that predict coping strategy variations; and (3)
identify the role that cost-coping plays in the relationship between financial stress and strain. In
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summary, the findings of this dissertation suggest that individuals affected by cancer cope with
the out-of-pocket costs of their care differently, often according to the cultural and social
positions. Cost-coping strategies vary and can either buffer or proliferate stress, and as a result,
can have serious impacts on health and mental health. The findings should be interpreted in light
of the its limitations as a cross-sectional study with a relatively small sample. Future studies are
needed to develop, evaluate and implement screening tools for the identification of cancer
patients and survivors at risk of encountering financial stress, and to develop interventions that
support self-advocacy and prevent the need to rely on care-altering and lifestyle-altering costcoping strategies.
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APPENDIX

Appendix 1. CancerCare Survey 4 - Financial and Insurance Issues
(Note: Programming instructions in blue)
Thank you for participating in our survey.
The purpose of this study is to learn about the impact of healthcare insurance and
financial issues on people with cancer. The information you provide will be used to
create support programs and influence policy to assist people with cancer.
As you answer the questions in this survey please base your answers on your personal
experiences and knowledge about healthcare insurance and finances related to your
cancer treatment.
The survey should take approximately 20 minutes to complete. All of your responses
will remain confidential and will not be tied to any information that could identify you.
First, please tell us a little bit about yourself:
(PN: Force a single response.)
1. What is your age?
❑ Under 25 years (Thank and terminate respondent)
❑ 25 to 34 years
❑ 35 to 44 years
❑ 45 to 54 years
❑ 55 to 64 years
❑ 65 to 74 years
❑ 75 or older

(PN: Allow entry of 5-digit ZIP code)
2. What ZIP code do you live in?

(PN: Force a single response.)
3. What is your current cancer status?
❑ Diagnosed but do not have a plan for treatment (Thank and terminate respondent)
❑ Diagnosed and have a plan for treatment but not yet begun treatment
❑ In active treatment
❑ Completed treatment and on maintenance therapy
❑ Completed treatment and not on maintenance therapy
❑ I do not have cancer / have never had cancer (Thank and terminate respondent❑
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Other

Please specify
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(PN: Force a single response but allow multiple responses.)
4. What type of health insurance do you have? Please select all that apply.
❑ Commercial/Private insurance through an employer
❑ Private insurance via Healthcare.gov (the insurance exchange)
❑ Medicare/Medicaid
❑ Private Medigap
❑ Tricare/Champus
❑ I don’t have health insurance (Thank and terminate respondent)
❑ Other (please specify)

(PN: Force a single response.)
5. How long ago were you first diagnosed with cancer?
❑ Within the last 12 months
❑ Between 13 months and 2 years ago
❑ Between 2 years and 4 years ago
❑ More than 4 years ago

(PN: 50% of the completes per region must be either Breast or Lung or Prostate or Colon/Rectal. 50% of
the completes per region must be from all other forms of cancer. Thank and terminate respondent once
quota is reached.)
(PN: Per region, an individual cancer type can account for no more than 35% of the regional
completions. Thank and terminate respondent once quota is reached.)
(PN: Force a single response.)
6. What type of cancer were you most recently diagnosed with?
❑ Bladder
❑ Brain
❑ Breast (Early Stage)
❑ Breast (Metastatic)
❑ Colon or rectal
❑ Endometrial, cervical, or ovarian
❑ Head/neck
❑ Kidney
❑ Leukemia
❑ Liver
❑ Lung
❑ Lymphoma
❑ Melanoma
❑ Myeloma
❑ Pancreatic
❑ Prostate
❑ Skin (Thank and terminate respondent)
❑ Stomach
❑ Thyroid
❑ Other (please specify)
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(PN: Display all statements on 1 screen.)
(PN: Force a single response for each statement.)
7. Below are some statements that people sometimes make when they talk about their health. Please
indicate how much you agree or disagree with each statement as it applies to you personally. If the
statement does not apply to you, please select N/A (not applicable).
Disagree
Strongly

a. When all is said and done, I am the person who
is responsible for taking care of my health
b. Taking an active role in my own health care is
the most important thing that affects my health
c. I know what each of my prescribed medications
do
d. I am confident that I can tell whether I need to
go to the doctor or whether I can take care of a
health problem myself.
e. I am confident that I can tell a doctor concerns I
have even when he or she does not ask.
f. I am confident that I can tell a nurse
practitioner, and/or physician assistant
concerns I have even when he or she does not
ask.
g. I am confident that I can follow through on
medical treatments I may need to do at home
h. I have been able to maintain (keep up with)
lifestyle changes, like eating right or exercising
i. I know how to prevent problems with my health
j. I am confident I can figure out solutions when
new problems arise with my health.
k. I am confident that I can maintain lifestyle
changes, like eating right and exercising, even
during times of stress.

Disagree

Agree

Agree
Strongly

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑
❑

❑
❑

❑
❑

❑
❑

❑
❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

(PN: Use wording “are you receiving“ if answer to Q3 “In active treatment”. Use wording “did you last
receive “if answer to Q3 “Completed treatment”.)
(PN: Force a single response.)
8.

N/A

At what kind of medical facility (are you receiving / did you last receive) your cancer treatment?
❑ Academic Medical Center/ Comprehensive Cancer Center
❑ Community Cancer Center
❑ Community hospital
❑ Private physician practice
❑ VA Medical Center
❑ Don’t know/ I’m not sure
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(PN: Skip Q9 if answer to Q3 “Diagnosed and have a plan for treatment but not yet begun treatment”.)
(PN: Force one response but allow multiple responses.)
9.

What type of cancer treatment have you received? Please select all that apply.
❑ Surgery
❑ Radiation
❑ Interventional Radiology
❑ Intravenous (I.V.) Chemotherapy
❑ Oral (pill) Chemotherapy
❑ Oral (pill) Hormonal Therapy
❑ Treatment targeted specifically for (PN: Pipe in Q6 answer.) cancer
❑ Immunotherapy
❑ Complementary or alternative therapies
❑ Don’t know/ I’m not sure (PN: Exclusive answer.)

(PN: Skip Q10 if answer to Q3 “Diagnosed and have a plan for treatment but not yet begun treatment”.)
(PN: Force one response.)
10. What was your employment status while you were being treated for cancer?
❑ I continued working full time
❑ I continued working part time
❑ I switched from working full time to working part time
❑ I stopped working
❑ Does not apply, I was not working before receiving treatment

The next set of questions is about your insurance coverage for your cancer care.
(PN: Force a single response.)
11. Overall, how well do you think you understand what your insurance covers for your cancer care?
Do Not
Understand At All

❑

Understand
Slightly

❑

Understand
Somewhat

❑

Understand
Very Well

❑

Understand
Completely

❑

(PN: Force a single response.)
12. Overall, how difficult or easy is it for you to understand what your insurance covers for your cancer
care?
Very
Difficult

❑

Somewhat
Difficult

❑

Neither
Difficult nor
Easy

❑

Somewhat
Easy

❑

Very
Easy

❑
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(PN: Force a single response.)
13. Overall, how satisfied are you with your insurance coverage for your cancer treatment?
Very
Dissatisfied

Moderately
Dissatisfied

❑

Neither Satisfied
nor Dissatisfied

❑

Moderately
Satisfied

❑

Very
Satisfied

❑

❑

(PN: Randomize list.)
(PN: Force a single response for each statement.)
14. How satisfied are you with the following aspects of your insurance coverage for your cancer
treatment?

Very
Dissatisfied

a. The choice of doctors
b. The choice of hospitals and/or

treatment centers
c. Affordability of co-payments
d. Affordability of deductibles
e. My ability to pay for
medications recommended by
my doctor
f. Amount I have to pay for the
tests recommended by my
doctor
g. In-network access to
psychological
counseling/support
h. Access to an insurance case
manager who explains/assists
with coverage issues
i. Access to Clinical trials
j. Access to newly approved
treatments or drugs
k. Access to advanced imaging
technology
l. Access to complementary
therapies such as acupuncture
or massage
m. Getting timely approvals for
tests or procedures
n. Access to genetic testing

❑

Somewhat
Dissatisfied

Neither
Satisfied nor
Dissatisfied

Somewhat
Satisfied

❑

❑
❑
❑

❑
❑
❑

❑
❑
❑

❑
❑
❑

❑
❑
❑

❑
❑
❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑
❑

❑
❑

❑
❑

❑
❑

❑
❑

❑
❑

15. Are you concerned you may lose your insurance if you are unable to work?

❑ Yes
❑ No

❑

No
Opinion

❑

(PN: Force a single response.)

❑

Very
Satisfied

❑
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(PN: Force a single response.)
16. Do you have access to alternative health insurance coverage if you are unable to work and lose your
employer sponsored coverage?

❑ Yes
❑ No

❑ Don’t know
(PN: Force a single response.)
17. Overall, how difficult or easy was it to find a doctor to treat you for cancer who takes your
insurance?
Very
Difficult

❑

Somewhat
Difficult

❑

Neither
Difficult or
Easy

❑

Somewhat
Easy

❑

Very
Easy

❑

(PN: Force a single response.)
18. If your insurance had no limits, would you have chosen a different doctor?
❑ Yes
❑ No
❑ I’m not sure
(PN: Force a single response.)
19. Overall, how difficult or easy was it to find a really good hospital or cancer treatment center that takes
your insurance?
Very
Difficult

❑

Somewhat
Difficult

❑

Neither
Difficult nor
Easy

❑

Somewhat
Easy

❑

Very
Easy

❑

(PN: Force a single response.)
20. If your insurance had no limits, would you have chosen a different hospital or treatment center?
❑ Yes
❑ No
❑ I’m not sure

(PN: Force a single response.)
21. If your insurance had no limits, would you have chosen to get different cancer treatment than you are
receiving/received?
❑
❑
❑

Yes
No
I’m not sure
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(PN: Force a single response.)
22. Have you heard of cancer treatment plans that are limited or required by an insurance company?
❑ Yes
❑ No
❑ I’m not sure

The next set of questions is about the financial issues related to your overall experience being treated for
cancer.
(PN: Force a single response.)
23. Thinking about the time when you were getting cancer treatment, how distressed (e.g. anxious,
extremely upset, or in emotional pain) were you from worrying thinking about your finances?
❑ Not at all distressed
❑ A little distressed
❑ Somewhat distressed
❑ Very distressed
❑ Extremely distressed

(PN: Force a single response.)
24. To what degree has your cancer treatment caused you financial hardship (ie. you are/were unable to
meet your financial obligations because of your cancer treatment trouble paying your bills)?
None

A little

Some

A lot

❑

❑

❑

❑

An extreme
amount

❑

(PN: Randomize list.)
(PN: Force a single response for each statement.)
25. How often do you do each of the following in order to REDUCE your expenses related to your cancer
treatment?

Never

a.

Rarely

Sometimes

Often

Always

N/A

Postpone or skip doctor's
appointments
Postpone or skip follow-up
testing

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

c.

Postpone or skip blood work

❑

❑

❑

❑

❑

❑

d.
e.

Postpone or not fill prescriptions
Delay or skip complementary
treatment (such as
acupuncture, massage therapy,
nutrition counseling)
Postpone or skip psychological
counseling or support
Skip dosages of prescribed
drugs

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

b.

f.
g.
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h.
i.

Cut pills in half
Apply for co-pay assistance to
cover medication costs
j. Discuss changing my treatment
to one that costs less
k. Choose to use a lower cost
medication than what the doctor
recommended
l. Apply for financial assistance
for non-medical expenses such
as transportation
m. Order medications on-line from
non-US sources
n. Apply for financial assistance
from my doctor/hospital

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

(PN: Force a single response but allow multiple responses.)
26. Who have you spoken to in your doctor’s office about treatment costs? Please select all that apply.
❑ Primary Care Physician
❑ Doctor treating me for cancer
❑ Physician Assistant or Nurse Practitioner
❑ Nurse
❑ Physician office staff member (e.g. receptionist, office manager)
❑ Patient Financial Services staff member
❑ Social Worker
❑ No one
❑ Other
(PN: Repeat Q27 for each person selected in Q26.)
(PN: Force a single response.)
27. When did you first discuss treatment costs of with the (PN: With each repeat of Q27 pipe in the
respective name of person selected in Q26.)?
❑ While scheduling my first appointment
❑ When first discussing treatment options with the doctor
❑ After learning what my insurance would cover but before starting treatment
❑ After starting treatment
❑ When I realized that paying the bills was becoming a problem
❑ Other

(PN: Force a single response but allow multiple responses.)
28. Who in your doctor’s office offered you help or advice about paying your medical bills? Please select
all that apply:
❑ Primary Care Physician
❑ Doctor treating me for cancer
❑ Patient Financial Services staff member
❑ Physician Assistant or Nurse Practitioner
❑ Nurse
❑ Physician office staff member (e.g. receptionist, office manager)
❑ Social Worker
❑ No one
❑ Other
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(PN: Ask Q29 for each Q28 selected.)
(PN: Force a single response for each person.)
29. How helpful was the advice about paying your medical bills that you received from each of the
following?
Very
Unhelpful

Primary Care Physician
Doctor treating me for cancer
Physician Assistant or Nurse
Practitioner
Nurse
Physician office staff member (e.g.
receptionist, office manager)
Patient Financial advisor
Other
Social Worker

Somewhat
Unhelpful

Neither Helpful
nor Unhelpful

Somewhat
Helpful

❑
❑

❑
❑

❑
❑

❑
❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑
❑
❑

❑
❑
❑

❑
❑
❑

❑
❑
❑

❑
❑

(PN: Ask Q30 if ALL answers to Q29 were “Very Unhelpful” or “Somewhat Unhelpful”.)
(PN: Force a single response.)
30. Overall, have you gotten the help you need to manage your medical bills?
❑ Yes
❑ No
❑ Not sure yet

(PN: Force a single response.)
31. How often do you feel your healthcare team takes your financial situation into consideration when
recommending treatment options?
Never

Rarely

❑

❑

Sometimes

❑

Often

❑

Always

❑

(PN: Force a single response.)
32. Which of the following BEST describes how often you discuss your financial concerns with
someone in your doctor’s office?
❑ Every appointment
❑ Whenever I get a bill
❑ Monthly
❑ Every few months
❑ Rarely
❑ Never

Very Helpful

❑
❑
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(PN: Randomize list.)
(PN: Force a single response but allow multiple responses.)
33. Which of the following have you experienced as a result of bills related to your cancer treatment? Please
select all that apply:
❑ I asked for financial help from a church or community organization
❑ I applied for financial assistance from a patient support organization
❑ I considered declaring bankruptcy
❑ I declared bankruptcy
❑ I borrowed money from a bank or credit union
❑ I cut back on non-essential expenses, such as vacations, movies, dining out
❑ I borrowed money from family/friends
❑ I moved to a less expensive home
❑ I missed rent/mortgage payments
❑ I cut back on groceries, transportation, clothing, tuition
❑ I missed paying bills such as heat, electricity, phone
❑ I applied for financial assistance from my doctor’s office or hospital
❑ Other (please specify)

(PN: Force a single response.)
34. Have you considered cashing in your life insurance to pay for your cancer treatment?
❑ Yes
❑ No
❑ Not applicable, I don’t have life insurance

(PN: Force a single response.)
35. Have you taken money from your pension plan or retirement account to pay for your cancer
treatment?
❑ Yes
❑ No
❑ Not applicable, I don’t have a pension plan or retirement account
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(PN: Randomize list.)
(PN: Force a single response for each statement.)
36. Thinking about your experience being treated for cancer, how often do you (or did you) do the
following?

Never

a. Determine the expense to you before
going to the emergency room
b. Estimate the cost to you before agreeing
to a treatment your doctor recommended
c. Appeal the denial of benefits from your
insurance company
d. Find out the cost to you before filling a
prescription for a treatment drug
e. Find out the cost to you before filling a
prescription for a drug that helps with
side effects or symptoms
f. Review the explanation of benefits from
your insurance company
g. Ask the insurance company for help in
understanding your coverage
h. Consider changing to a different doctor
because of cost
i. Find out the cost to you before getting
lab tests or scans
j. Agree to a test or procedure that your
insurance didn’t cover
k. Consider non-traditional treatment that
costs less

Rarely

Sometimes

Often

Always

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

(PN: Show following definition on same page as each of next 3 questions.)
A “formulary” is a list of drugs that your insurer covers. There are often several levels (or tiers)
within the formulary and the amount of coverage for a drug varies depending on the level it is in.

(PN: Force a single response.)
37. Are you familiar with term “formulary” as described above?
❑ Yes
❑ No

(PN: Force a single response.)
38. Are you aware that insurance plans often have several levels of coverage for cancer drugs and that the
amount you pay out of pocket may change depending on the drugs your doctor prescribes?
❑
❑
❑

Yes
No
I’m not sure
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(PN: Force a single response.)
39. Are you aware that your co-pay amount may be different depending on if you are receiving
treatment in the hospital or in your doctor’s office?
❑ Yes
❑ No
❑ I’m not sure
(PN: Only ask Q40 if answer to Q4 was “Medicare/Medicaid” or “Private Medigap” AND answer to Q9
was “Intravenous Chemotherapy (I.V.)”.)
40. Was your infusion (ie. intravenous or I.V.) therapy covered under Medicare Part B (your medical
benefits)?
❑ Yes
❑ No
❑ I’m not sure
(PN: Only ask Q41 if answer to Q40 was “Yes”.)
41. On average, what was the co-pay per infusion?
❑
❑
❑
❑
❑

Less than $50
$51 - $150
$151 - $300
$301 - $500
More than $500

(PN: Only ask Q42 if answer to Q4 was “Medicare/Medicaid” or “Private Medigap” AND answer to Q9
was “Oral Chemotherapy (Pill)” or “Oral Hormonal Therapy (Pill)”.)
42. Was your oral therapy covered under Medicare Part D (your drug benefits)?
❑ Yes
❑ No
❑ I’m not sure
(PN: Only ask Q43 if answer to Q42 was “Yes”.)
43. On average, what was the co-pay per prescription?
❑ Less than $50
❑ $51 - $150
❑ $151 - $300
❑ $301 - $500
❑ More than $500
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(PN: Randomize list.)
(PN: Force a single response for each statement.)
44. How difficult or easy was it for you to determine the out-of pocket cost of each of the following
BEFORE you incurred the expense?
Very
Difficult

a. Scans and X-rays
b. Procedures

c. Treatments
d. Physician fees
e. Hospital fees

❑
❑
❑
❑
❑

Somewhat
Difficult

❑
❑
❑
❑
❑

Neither
Difficult nor Easy

Somewhat
Easy

❑
❑
❑
❑
❑

Very
Easy

❑
❑
❑
❑
❑

Not
Applicable

❑
❑
❑
❑
❑

❑
❑
❑
❑
❑

(PN: Randomize list.)
(PN: Force a single response for each statement.)
45. Thinking about the time you were getting cancer treatment, on average, how much did you spend out
of pocket each month on the following? Your best estimate will do.
Less than
$100

a. Co-payments and deductibles

for drugs, doctor visits and tests
b. Non-prescription medications
(that is, over-the-counter drugs)
c. Services to help with symptoms
and side effects such as
acupuncture or massage
therapy
d. Transportation to and from
clinic visits, baby-sitting,
e. Special clothing, wigs, etc.

$101-250

$251-500

More than
$500

Don’t know/
I’m not sure

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

❑

(PN: Force response)
46. What percent of your total cancer treatment costs do you think have been covered by your
insurance? Your best estimate will do.
% of total treatment costs covered by insurance
❑ I’m not sure

The remaining few questions are asked to provide us with some demographic information so we can
better understand the study findings.
(PN: Force a single response.)
47. What is your gender?
❑ Male
❑ Female
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(PN: Force a single response.)
48. What Is Your Ethnicity?
❑ African American
❑ Asian
❑ Hispanic
❑ Pacific Islander
❑ White (not Hispanic)
❑ Multi-racial
❑ Other

(PN: Force a single response.)
49. What was your total 2014 household income before taxes?
❑ Less than $25,000
❑ $25,000 to $34,999
❑ $35,000 to $49,999
❑ $50,000 to $74,999
❑ $75,000 to $99,999
❑ $100,000 to $149,999
❑ $150,000 or more
❑ Prefer not to answer
(PN: Force a single response.)
50. What is the highest level of education or degree you have completed?
❑
❑
❑
❑
❑
❑
❑

Less than high school
High school graduate (includes equivalency)
Some college, no degree
Associate's degree
Bachelor's degree
Master’s degree
Doctorate / professional degree

(PN: Allow multiple responses.)
51. If you have Commercial/Private insurance, who is your provider? Please select all that apply.
❑ Private insurance through an employer
❑ United Healthcare
❑ Aetna
❑ Cigna
❑ Humana
❑ Kaiser Permanente
❑ Blue Cross Blue Shield
❑ Other (please specify)
This completes the survey. Thank you very much for your feedback.
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Appendix 2. Signed Data Use Agreement
Data Use Agreement: CancerCare Data Set
All individuals with access to the data are to sign and submit along with a CancerCare Manuscript Proposal

Investigator Name: Meredith Doherty
Investigator Institution:
Project Title:
Lead Data Manager:
CancerCare Data Set will be released to the above referenced investigator, as indicated here. Methodology and

survey demographics are attached:
(a) Patient Survey 1: Understanding the Diagnosis of Cancer
(b) Patient Survey 2: Participation in Treatment Planning and Decisions
(c) Patient Survey 3: Communication with the Care Team
(d) Patient Survey 4: Financial and Insurance Issues
(e) Patient Survey 5: Symptoms, Side Effects and Quality of Life
(f) Patient Survey 6: Survivorship

In accepting this data from CancerCare, the Investigator agrees to use the data only for the CancerCare approved
research project. (Attach Manuscript Proposal)
Investigator agrees to submit a new proposal to CancerCare for any new project in which the data is to be used and
will not proceed to use the data for an additional project with_out approval and a signed agreement from
CancerCare.

The data may only be shared within the_ team w d cting the analysis pr ject. Requests from other individuals for
access to the data should be referred to the CancerCare Data Set Manager (Ellen Sonet).
The investigator agrees to follow the CancerCare Data Set Policies on Data Management and Security as follows:
1. Use or disclose the data set only as permitted by this Agreement or as required by law;
2. Use appropriate safeguards to prevent use or disclosure of the DATA SET other than as permitted by this
Agreement or required by law;
3. Report to CancerCare any use or disclosure of the data set of which it becomes aware that is not permitted by this
Agreement or required by law, including the presence of prohibited identifiers in the data set;
4. Require any of Investigators' subcontractors or,agents that receive or have access to the data set to agree to the same
restrictions and conditions on the use and/or disclosure of the data set that apply to Investigator under this
Agreement; and
5. Not use the information in the data set, alone or in combination, to identify or contact the individuals who are
data subjects.

The term of this Agreement begins as of the effective date and terminates 5 years from effective date. If the
Investigator desires to keep the data set for a longer period, a justification in writing should be made to
CancerCare.

Investigator may terminate this agreement at any time by notifying CancerCare and returning or destroying the data
set.
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CancerCare will provide written notice to Investigator withi ten _(1_0).days. of any determination that he/she has

breached a material term of this Agreement. CancerCare shall afford Investigator an opportunity to cure said alleged
material breach upon mutually agreeable terms. Failure to agree on mutually agreeable terms for cure within thirty
{30) days shall be grounds for the immediate termination of this Agreement by CancerCare.

Ellen Sonet will serve as the lead data manager for this analytic project and will serve as the liaison with the
CancerCare.

All CancerCare Data Set publications must be prepared in collaboration with CancerCare and co-authored by a
CancerCare staff member. Any exceptions to this requirement must be noted and agreed to as part

of this agreement.
Exception: Meredith Doherty may access this data for her dissertation and derivative
publications, which are exempt from CancerCare co-author requirements.
Copies of all manuscripts arising from the project must be sent to the CancerCare prior to
publication, for reference.
Any publication using CancerCare Data Set data must acknowledge the contributions of the
CancerCare Data Set to the project with the following citation: "This publication was supported by
CancerCare and is based on data from its :20_1_6 Patient Access and Engagement Study."
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Effective Date:

2//( /]

81
Appendix 3. IRB Determination Notice
University Integrated Institutional Review Board
205 East 42

nd

Street

New York, NY 10017
http://www.cuny.edu/research/compliance.html

Determination Notice
Activity Does Not Require CUNY HRPP/IRB Review
06/28/2017
Meredith Doherty,
Hunter College
RE: IRB File #2017-0067
Exploring Themes of Patient Access and Engagement in Cancer Care: Financial Wellbeing,
Quality of Life and Value.
Dear Meredith Doherty,
The above-referenced research proposal was reviewed on 06/28/2017. Based on the information you
have provided, the proposed research does not require CUNY HRPP or IRB review because:
[]

It does not meet the CUNY HRPP definition of research: A systematic investigation,
including research development, testing and evaluation, designed to develop or contribute to
generalizable knowledge.

[X] It does not involve human subjects as defined by CUNY HRPP: A living individual about
whom an investigator (whether professional or student) conducting research obtains (1) data
through intervention or interaction with the individual, or (2) identifiable private information.
[]

CUNY is not engaged in the proposed research: CUNY employees or agents 1 obtain, for
the purposes of the research project, (1) data about the subjects of the research through
intervention or interaction with them; (2) identifiable private information about the subjects of
the research; or (3) the informed consent of human subjects for the research.

Comments:
Please refer to CUNY HRPP Guidance: When is CUNY HRPP or IRB Review Required for further
clarification regarding these criteria. Should your proposed activity change, please re-submit to
the CUNY HRPP for re-evaluation of this determination.
1

Employees or agents refers to individuals who: (1) act on behalf of CUNY; (2) exercise institutional authority or responsibility; or (3) perform

institutionally designated activities. Employees or agents can include staff, students, contractors, and volunteers, among others, regardless of whether
the individual is receiving compensation.

If you have any questions, please contact:
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